www.insidertrades.com
Open in
urlscan Pro
2606:4700:3030::6815:7001
Public Scan
Submitted URL: https://email.analystratings.net/ls/click?upn=u001.WeKo-2BCuHku2kJmVIsYmGxsYmJ5tlN1JIFNOQtoSEGkIVjFH-2FfEah4F5Giggxaui5v90eWh1rDp...
Effective URL: https://www.insidertrades.com/ultragenyx-pharmaceutical-inc-stock/?AccountID=13091940&hash=%ITHash%&utm_source=newsletter&utm_...
Submission: On January 04 via api from BE — Scanned from US
Effective URL: https://www.insidertrades.com/ultragenyx-pharmaceutical-inc-stock/?AccountID=13091940&hash=%ITHash%&utm_source=newsletter&utm_...
Submission: On January 04 via api from BE — Scanned from US
Form analysis
1 forms found in the DOMPOST ./?AccountID=13091940&hash=%25ITHash%25&utm_source=newsletter&utm_medium=email&utm_campaign=newsletterclick
<form method="post" action="./?AccountID=13091940&hash=%25ITHash%25&utm_source=newsletter&utm_medium=email&utm_campaign=newsletterclick" id="form1">
<div class="aspNetHidden">
<input type="hidden" name="__VIEWSTATE" id="__VIEWSTATE" value="/wEPDwUKLTY5NjUxMzU2NmRkv0F8Fxjk24IE6ZSv3CkoC2sZuBoCGFx4Q65RQaVLJDU=">
</div>
<div class="aspNetHidden">
<input type="hidden" name="__VIEWSTATEGENERATOR" id="__VIEWSTATEGENERATOR" value="FF138D8B">
</div>
<div class="page-body">
<div class="container">
<h1>RARE Insider Trading</h1>
<ul class="horizontal-ul">
<li>
<a href="#insider-trading-chart">Insider Trading Chart</a>
</li>
<li>
<a href="#insider-trading-history">Insider Trading History</a>
</li>
<li>
<a href="#insider-trading-faq">Frequently Asked Questions</a>
</li>
<li>
<a href="#about">About</a>
</li>
</ul>
<div class="row d-sm-flex super-border-top super-border-bottom py-1">
<div class="col"><b>Insider Ownership Percentage:</b> 5.80%</div>
<div class="col"><b>Insider Buying (Last 12 Months):</b> $0.00</div>
<div class="col"><b>Insider Selling (Last 12 Months):</b> $5,610,824.29</div>
</div>
<div id="insider-trading-chart">
<h2>Ultragenyx Pharmaceutical Insider Trading History Chart</h2>
<p class="sr-only">This chart shows the insider buying and selling history at Ultragenyx Pharmaceutical by year and by quarter.</p>
<a href="#price-history" class="sr-only sr-only-focusable">Skip Chart</a><a href="#insider-trading-history" class="sr-only sr-only-focusable">Chart Data in Insider Trading History Table</a>
<div id="insiderChart" class="dv-chart" style="height:350px;margin-bottom:3em;"></div>
</div>
<h2 id="price-history">Ultragenyx Pharmaceutical Share Price & Price History</h2>
<div class="row d-sm-flex super-border-top super-border-bottom py-1" style="align-items: baseline; -ms-align-items: baseline;">
<div class="col h1 m-0" style="position: relative;top: 3px;">
<span class="sr-only">Current Price: </span><sup>$</sup>41.50
</div>
<div class="col" style="flex:1;-ms-flex:1;">
<div class="c-brown semibold">
<span class="sr-only">Price Change: </span>▲ <span class="sr-only">Price Increase of </span> +0.35 (0.85%)
</div>
</div>
<div class="col" style="padding-bottom: 3px;">As of 01/3/2025 06:39 PM ET</div>
</div>
<div class="pt-1">
<p class="sr-only">This chart shows the closing price history over time for RARE up to the past year.</p>
<a href="#sec-filings" class="sr-only sr-only-focusable">Skip Chart and Table Data</a><a href="#insider-trading-history" class="sr-only sr-only-focusable">Price Data in Insider Trading History Table</a>
<div id="cphPrimaryContent_pnlMiniChart">
<div class="text-right priceChartOptions"> Days: <span class="draw-price-chart a-green" id="draw30" style="cursor:pointer;">30</span> | <span class="draw-price-chart a-green" id="draw90" style="cursor:pointer;">90</span> | <span
class="draw-price-chart a-green active" id="draw365" style="cursor:pointer;">365</span>
</div>
<div class="mt-1 border">
<div id="priceChart" class="dv-chart" style="height:333px;">
</div>
</div>
</div>
</div>
</div>
<div class="bg-gray mt-1">
<div class="container">
<a target="_blank" rel="sponsored noopener" style="text-decoration:none;display:inline-block;width:100%;" href="https://www.marketbeat.com/scripts/redirect.aspx?TriggeredCampaignID=11263&UserID=13091940&Placement=NativeDisplay&Source=NativeDisplay&interstitial=1"><div class="row d-sm-flex c-green" style="font-weight:300;line-height:1.3;"><div class="col" style="float:left; -webkit-box-flex: 0; -ms-flex: 0 0 auto; flex: 0 0 auto; width: auto; max-width: none;"><div class="my-1 i-clipped lazy" style="width:153px; height:138px; padding: 0;background:url("https://www.marketbeat.com/images/webpush/files/thumb_2067push_RedSuite500x500.png");background-size:cover;background-position: center;max-width:23vw;max-height:20.75vw;"></div></div><div class="col pb-1" style="-webkit-box-flex: 1; -ms-flex: 1; flex: 1; width: auto; max-width: none;"><div class="pt-1"><div class="green-accent"></div><div class="h2 mt-1">Target More Reliable Returns in 2025</div><div class="byline-size o-80" style="margin-bottom: 10px;"><span>From Unstoppable Prosperity | Ad</span></div><div style="clear:both;">[LIVE] How the Pros are Trading Options in 2025
Charles Payne reveals beginner-friendly options strategies for the New Year
</div><div class="a-green a-dark-green mt-1">Just click here to claim your seat at the LIVE Power of Options event</div></div></div></div></a><img loading="lazy"
src="https://www.marketbeat.com/scripts/TriggeredCampaignPixel.ashx?TriggeredCampaignID=11263&Placement=NativeDisplay&Source=NativeDisplay" alt="" height="1" width="1">
</div>
</div>
<div class="see-more-section">
<div class="container" id="insider-trading-history">
<h2>Ultragenyx Pharmaceutical Insider Trading History</h2>
<table class="tdt sbt">
<thead>
<tr>
<th data-sort="int">Transaction Date</th>
<th data-sort="string">Insider Name</th>
<th data-sort="string">Title</th>
<th data-sort="string" style="min-width:54px;">Buy/Sell</th>
<th data-sort="float">Number of Shares</th>
<th data-sort="float">Average Share Price</th>
<th data-sort="float">Total Transaction</th>
<th data-sort="int">Shares Held After Transaction</th>
<th>Details</th>
</tr>
</thead>
<tbody>
<tr>
<td data-sort="20241230000000">12/30/2024</td>
<td>Emil D Kakkis</td>
<td>CEO</td>
<td>Sell</td>
<td>11,727</td>
<td>$42.23</td>
<td>$495,231.21</td>
<td>2,183,985</td>
<td>
<a rel="nofollow noopener" href="https://www.sec.gov/Archives/edgar/data/1248093/000095017024141485/xslF345X05/ownership.xml" target="_blank" title="View SEC Filing for Emil D Kakkis’s Sell of 11,727 Ultragenyx Pharmaceutical shares on 12/30/2024"><img src="/images/insider-trades-icon-details.svg?v=2" width="27" height="27" alt="View SEC Filing Icon" loading="lazy"></a>
</td>
</tr>
<tr>
<td data-sort="20241210000000">12/10/2024</td>
<td>Emil D Kakkis</td>
<td>CEO</td>
<td>Sell</td>
<td>8,273</td>
<td>$50.00</td>
<td>$413,650.00</td>
<td>2,195,712</td>
<td>
<a rel="nofollow noopener" href="https://www.sec.gov/Archives/edgar/data/1248093/000095017024135521/xslF345X05/ownership.xml" target="_blank" title="View SEC Filing for Emil D Kakkis’s Sell of 8,273 Ultragenyx Pharmaceutical shares on 12/10/2024"><img src="/images/insider-trades-icon-details.svg?v=2" width="27" height="27" alt="View SEC Filing Icon" loading="lazy"></a>
</td>
</tr>
<tr>
<td data-sort="20241010000000">10/10/2024</td>
<td><a href="/ultragenyx-pharmaceutical-inc-stock/howard-horn-1/">Howard Horn</a></td>
<td>CFO</td>
<td>Sell</td>
<td>7,465</td>
<td>$52.76</td>
<td>$393,853.40</td>
<td>92,301</td>
<td>
<a rel="nofollow noopener" href="https://www.sec.gov/Archives/edgar/data/1515673/000095017024114378/xslF345X05/ownership.xml" target="_blank" title="View SEC Filing for Howard Horn’s Sell of 7,465 Ultragenyx Pharmaceutical shares on 10/10/2024"><img src="/images/insider-trades-icon-details.svg?v=2" width="27" height="27" alt="View SEC Filing Icon" loading="lazy"></a>
</td>
</tr>
<tr>
<td data-sort="20240903000000">9/3/2024</td>
<td>Emil D Kakkis</td>
<td>CEO</td>
<td>Sell</td>
<td>20,000</td>
<td>$55.85</td>
<td>$1,117,000.00</td>
<td>2,223,985</td>
<td>
<a rel="nofollow noopener" href="https://www.sec.gov/Archives/edgar/data/1248093/000095017024103811/xslF345X05/ownership.xml" target="_blank" title="View SEC Filing for Emil D Kakkis’s Sell of 20,000 Ultragenyx Pharmaceutical shares on 9/3/2024"><img src="/images/insider-trades-icon-details.svg?v=2" width="27" height="27" alt="View SEC Filing Icon" loading="lazy"></a>
</td>
</tr>
<tr>
<td data-sort="20240903000000">9/3/2024</td>
<td><a href="/ultragenyx-pharmaceutical-inc-stock/theodore-alan-huizenga/">Theodore Alan Huizenga</a></td>
<td>CAO</td>
<td>Sell</td>
<td>91</td>
<td>$56.19</td>
<td>$5,113.29</td>
<td>41,551</td>
<td>
<a rel="nofollow noopener" href="https://www.sec.gov/Archives/edgar/data/1515673/000095017024103807/xslF345X05/ownership.xml" target="_blank" title="View SEC Filing for Theodore Alan Huizenga’s Sell of 91 Ultragenyx Pharmaceutical shares on 9/3/2024"><img src="/images/insider-trades-icon-details.svg?v=2" width="27" height="27" alt="View SEC Filing Icon" loading="lazy"></a>
</td>
</tr>
<tr>
<td data-sort="20240806000000">8/6/2024</td>
<td>Emil D Kakkis</td>
<td>CEO</td>
<td>Sell</td>
<td>20,000</td>
<td>$50.17</td>
<td>$1,003,400.00</td>
<td>2,243,985</td>
<td>
<a rel="nofollow noopener" href="https://www.sec.gov/Archives/edgar/data/1248093/000095017024092608/xslF345X05/ownership.xml" target="_blank" title="View SEC Filing for Emil D Kakkis’s Sell of 20,000 Ultragenyx Pharmaceutical shares on 8/6/2024"><img src="/images/insider-trades-icon-details.svg?v=2" width="27" height="27" alt="View SEC Filing Icon" loading="lazy"></a>
</td>
</tr>
<tr>
<td data-sort="20240702000000">7/2/2024</td>
<td><a href="/ultragenyx-pharmaceutical-inc-stock/corazon-corsee-d-sanders-1/">Corsee D. Sanders</a></td>
<td>Director</td>
<td>Sell</td>
<td>584</td>
<td>$40.98</td>
<td>$23,932.32</td>
<td>12,009</td>
<td>
<a rel="nofollow noopener" href="https://www.sec.gov/Archives/edgar/data/1515673/000095017024081302/xslF345X05/ownership.xml" target="_blank" title="View SEC Filing for Corazon (Corsee) D Sanders’s Sell of 584 Ultragenyx Pharmaceutical shares on 7/2/2024"><img src="/images/insider-trades-icon-details.svg?v=2" width="27" height="27" alt="View SEC Filing Icon" loading="lazy"></a>
</td>
</tr>
<tr>
<td data-sort="20240612000000">6/12/2024</td>
<td><a href="/ultragenyx-pharmaceutical-inc-stock/karah-herdman-parschauer/">Karah Herdman Parschauer</a></td>
<td>EVP</td>
<td>Sell</td>
<td>9,806</td>
<td>$45.00</td>
<td>$441,270.00</td>
<td>57,981</td>
<td>
<a rel="nofollow noopener" href="https://www.sec.gov/Archives/edgar/data/1515673/000095017024072621/xslF345X05/ownership.xml" target="_blank" title="View SEC Filing for Karah Herdman Parschauer’s Sell of 9,806 Ultragenyx Pharmaceutical shares on 6/12/2024"><img src="/images/insider-trades-icon-details.svg?v=2" width="27" height="27" alt="View SEC Filing Icon" loading="lazy"></a>
</td>
</tr>
<tr>
<td data-sort="20240610000000">6/10/2024</td>
<td><a href="/ultragenyx-pharmaceutical-inc-stock/corazon-corsee-d-sanders-1/">Corsee D. Sanders</a></td>
<td>Director</td>
<td>Sell</td>
<td>1,737</td>
<td>$41.10</td>
<td>$71,390.70</td>
<td>7,248</td>
<td>
<a rel="nofollow noopener" href="https://www.sec.gov/Archives/edgar/data/1515673/000095017024071548/xslF345X05/ownership.xml" target="_blank" title="View SEC Filing for Corazon (Corsee) D Sanders’s Sell of 1,737 Ultragenyx Pharmaceutical shares on 6/10/2024"><img src="/images/insider-trades-icon-details.svg?v=2" width="27" height="27" alt="View SEC Filing Icon" loading="lazy"></a>
</td>
</tr>
<tr>
<td data-sort="20240418000000">4/18/2024</td>
<td><a href="/ultragenyx-pharmaceutical-inc-stock/eric-crombez/">Eric Crombez</a></td>
<td>EVP</td>
<td>Sell</td>
<td>142</td>
<td>$44.10</td>
<td>$6,262.20</td>
<td>48,785</td>
<td>
<a rel="nofollow noopener" href="https://www.sec.gov/Archives/edgar/data/1515673/000095017024046055/xslF345X05/ownership.xml" target="_blank" title="View SEC Filing for Eric Crombez’s Sell of 142 Ultragenyx Pharmaceutical shares on 4/18/2024"><img src="/images/insider-trades-icon-details.svg?v=2" width="27" height="27" alt="View SEC Filing Icon" loading="lazy"></a>
</td>
</tr>
<tr>
<td data-sort="20240311000000">3/11/2024</td>
<td><a href="/ultragenyx-pharmaceutical-inc-stock/thomas-richard-kassberg/">Thomas Richard Kassberg</a></td>
<td>EVP</td>
<td>Sell</td>
<td>11,509</td>
<td>$49.93</td>
<td>$574,644.37</td>
<td>252,823</td>
<td>
<a rel="nofollow noopener" href="https://www.sec.gov/Archives/edgar/data/1303811/000095017024029780/xslF345X05/ownership.xml" target="_blank" title="View SEC Filing for Thomas Richard Kassberg’s Sell of 11,509 Ultragenyx Pharmaceutical shares on 3/11/2024"><img src="/images/insider-trades-icon-details.svg?v=2" width="27" height="27" alt="View SEC Filing Icon" loading="lazy"></a>
</td>
</tr>
<tr>
<td data-sort="20240307000000">3/7/2024</td>
<td><a href="/ultragenyx-pharmaceutical-inc-stock/matthew-k-fust-2/">Matthew K. Fust</a></td>
<td>Director</td>
<td>Sell</td>
<td>12,195</td>
<td>$50.88</td>
<td>$620,481.60</td>
<td>14,860</td>
<td>
<a rel="nofollow noopener" href="https://www.sec.gov/Archives/edgar/data/1397266/000095017024029040/xslF345X05/ownership.xml" target="_blank" title="View SEC Filing for Matthew K Fust’s Sell of 12,195 Ultragenyx Pharmaceutical shares on 3/7/2024"><img src="/images/insider-trades-icon-details.svg?v=2" width="27" height="27" alt="View SEC Filing Icon" loading="lazy"></a>
</td>
</tr>
<tr>
<td data-sort="20240301000000">3/1/2024</td>
<td><a href="/ultragenyx-pharmaceutical-inc-stock/john-richard-pinion/">John Richard Pinion</a></td>
<td>Insider</td>
<td>Sell</td>
<td>4,173</td>
<td>$53.76</td>
<td>$224,340.48</td>
<td>89,268</td>
<td>
<a rel="nofollow noopener" href="https://www.sec.gov/Archives/edgar/data/1515673/000095017024026648/xslF345X05/ownership.xml" target="_blank" title="View SEC Filing for John Richard Pinion’s Sell of 4,173 Ultragenyx Pharmaceutical shares on 3/1/2024"><img src="/images/insider-trades-icon-details.svg?v=2" width="27" height="27" alt="View SEC Filing Icon" loading="lazy"></a>
</td>
</tr>
<tr>
<td data-sort="20240301000000">3/1/2024</td>
<td><a href="/ultragenyx-pharmaceutical-inc-stock/karah-herdman-parschauer/">Karah Herdman Parschauer</a></td>
<td>EVP</td>
<td>Sell</td>
<td>3,756</td>
<td>$53.76</td>
<td>$201,922.56</td>
<td>67,340</td>
<td>
<a rel="nofollow noopener" href="https://www.sec.gov/Archives/edgar/data/1515673/000095017024026629/xslF345X05/ownership.xml" target="_blank" title="View SEC Filing for Karah Herdman Parschauer’s Sell of 3,756 Ultragenyx Pharmaceutical shares on 3/1/2024"><img src="/images/insider-trades-icon-details.svg?v=2" width="27" height="27" alt="View SEC Filing Icon" loading="lazy"></a>
</td>
</tr>
<tr>
<td data-sort="20240301000000">3/1/2024</td>
<td><a href="/ultragenyx-pharmaceutical-inc-stock/theodore-alan-huizenga/">Theodore Alan Huizenga</a></td>
<td>CAO</td>
<td>Sell</td>
<td>341</td>
<td>$53.76</td>
<td>$18,332.16</td>
<td>41,380</td>
<td>
<a rel="nofollow noopener" href="https://www.sec.gov/Archives/edgar/data/1515673/000095017024026641/xslF345X05/ownership.xml" target="_blank" title="View SEC Filing for Theodore Alan Huizenga’s Sell of 341 Ultragenyx Pharmaceutical shares on 3/1/2024"><img src="/images/insider-trades-icon-details.svg?v=2" width="27" height="27" alt="View SEC Filing Icon" loading="lazy"></a>
</td>
</tr>
<tr>
<td data-sort="20231023000000">10/23/2023</td>
<td><a href="/ultragenyx-pharmaceutical-inc-stock/thomas-richard-kassberg/">Thomas Richard Kassberg</a></td>
<td>EVP</td>
<td>Sell</td>
<td>39,878</td>
<td>$32.78</td>
<td>$1,307,200.84</td>
<td>246,860</td>
<td>
<a rel="nofollow noopener" href="https://www.sec.gov/Archives/edgar/data/1303811/000120919123053487/xslF345X05/doc4.xml" target="_blank" title="View SEC Filing for Thomas Richard Kassberg’s Sell of 39,878 Ultragenyx Pharmaceutical shares on 10/23/2023"><img src="/images/insider-trades-icon-details.svg?v=2" width="27" height="27" alt="View SEC Filing Icon" loading="lazy"></a>
</td>
</tr>
<tr>
<td data-sort="20231019000000">10/19/2023</td>
<td>Emil D Kakkis</td>
<td>CEO</td>
<td>Sell</td>
<td>47,853</td>
<td>$33.52</td>
<td>$1,604,032.56</td>
<td>599,743</td>
<td>
<a rel="nofollow noopener" href="https://www.sec.gov/Archives/edgar/data/1248093/000120919123053351/xslF345X05/doc4.xml" target="_blank" title="View SEC Filing for Emil D Kakkis’s Sell of 47,853 Ultragenyx Pharmaceutical shares on 10/19/2023"><img src="/images/insider-trades-icon-details.svg?v=2" width="27" height="27" alt="View SEC Filing Icon" loading="lazy"></a>
</td>
</tr>
<tr>
<td data-sort="20230907000000">9/7/2023</td>
<td><a href="/ultragenyx-pharmaceutical-inc-stock/theodore-alan-huizenga/">Theodore Alan Huizenga</a></td>
<td>CAO</td>
<td>Sell</td>
<td>2,163</td>
<td>$40.80</td>
<td>$88,250.40</td>
<td>23,614</td>
<td>
<a rel="nofollow noopener" href="https://www.sec.gov/Archives/edgar/data/1515673/000120919123048905/xslF345X05/doc4.xml" target="_blank" title="View SEC Filing for Theodore Alan Huizenga’s Sell of 2,163 Ultragenyx Pharmaceutical shares on 9/7/2023"><img src="/images/insider-trades-icon-details.svg?v=2" width="27" height="27" alt="View SEC Filing Icon" loading="lazy"></a>
</td>
</tr>
<tr>
<td data-sort="20230905000000">9/5/2023</td>
<td><a href="/ultragenyx-pharmaceutical-inc-stock/erik-harris/">Erik Harris</a></td>
<td>EVP</td>
<td>Sell</td>
<td>6,000</td>
<td>$37.96</td>
<td>$227,760.00</td>
<td>51,281</td>
<td>
<a rel="nofollow noopener" href="https://www.sec.gov/Archives/edgar/data/1515673/000120919123048491/xslF345X05/doc4.xml" target="_blank" title="View SEC Filing for Erik Harris’s Sell of 6,000 Ultragenyx Pharmaceutical shares on 9/5/2023"><img src="/images/insider-trades-icon-details.svg?v=2" width="27" height="27" alt="View SEC Filing Icon" loading="lazy"></a>
</td>
</tr>
<tr>
<td data-sort="20230901000000">9/1/2023</td>
<td><a href="/ultragenyx-pharmaceutical-inc-stock/theodore-alan-huizenga/">Theodore Alan Huizenga</a></td>
<td>CAO</td>
<td>Sell</td>
<td>970</td>
<td>$37.15</td>
<td>$36,035.50</td>
<td>23,777</td>
<td>
<a rel="nofollow noopener" href="https://www.sec.gov/Archives/edgar/data/1515673/000120919123048489/xslF345X05/doc4.xml" target="_blank" title="View SEC Filing for Theodore Alan Huizenga’s Sell of 970 Ultragenyx Pharmaceutical shares on 9/1/2023"><img src="/images/insider-trades-icon-details.svg?v=2" width="27" height="27" alt="View SEC Filing Icon" loading="lazy"></a>
</td>
</tr>
<tr>
<td data-sort="20230630000000">6/30/2023</td>
<td><a href="/ultragenyx-pharmaceutical-inc-stock/corazon-corsee-d-sanders-1/">Corsee D. Sanders</a></td>
<td>Director</td>
<td>Sell</td>
<td>585</td>
<td>$46.76</td>
<td>$27,354.60</td>
<td>8,985</td>
<td>
<a rel="nofollow noopener" href="https://www.sec.gov/Archives/edgar/data/1515673/000120919123040269/xslF345X04/doc4.xml" target="_blank" title="View SEC Filing for Corazon (Corsee) D Sanders’s Sell of 585 Ultragenyx Pharmaceutical shares on 6/30/2023"><img src="/images/insider-trades-icon-details.svg?v=2" width="27" height="27" alt="View SEC Filing Icon" loading="lazy"></a>
</td>
</tr>
<tr>
<td data-sort="20230619000000">6/19/2023</td>
<td><a href="/ultragenyx-pharmaceutical-inc-stock/erik-harris/">Erik Harris</a></td>
<td>EVP</td>
<td>Sell</td>
<td>305</td>
<td>$48.20</td>
<td>$14,701.00</td>
<td>57,281</td>
<td>
<a rel="nofollow noopener" href="https://www.sec.gov/Archives/edgar/data/1515673/000120919123038885/xslF345X04/doc4.xml" target="_blank" title="View SEC Filing for Erik Harris’s Sell of 305 Ultragenyx Pharmaceutical shares on 6/19/2023"><img src="/images/insider-trades-icon-details.svg?v=2" width="27" height="27" alt="View SEC Filing Icon" loading="lazy"></a>
</td>
</tr>
<tr>
<td data-sort="20230608000000">6/8/2023</td>
<td><a href="/ultragenyx-pharmaceutical-inc-stock/corazon-corsee-d-sanders-1/">Corsee D. Sanders</a></td>
<td>Director</td>
<td>Sell</td>
<td>1,485</td>
<td>$51.65</td>
<td>$76,700.25</td>
<td>9,570</td>
<td>
<a rel="nofollow noopener" href="https://www.sec.gov/Archives/edgar/data/1515673/000120919123035690/xslF345X04/doc4.xml" target="_blank" title="View SEC Filing for Corazon (Corsee) D Sanders’s Sell of 1,485 Ultragenyx Pharmaceutical shares on 6/8/2023"><img src="/images/insider-trades-icon-details.svg?v=2" width="27" height="27" alt="View SEC Filing Icon" loading="lazy"></a>
</td>
</tr>
<tr>
<td data-sort="20230518000000">5/18/2023</td>
<td><a href="/ultragenyx-pharmaceutical-inc-stock/john-richard-pinion/">John Richard Pinion</a></td>
<td>Insider</td>
<td>Sell</td>
<td>2,012</td>
<td>$50.00</td>
<td>$100,600.00</td>
<td>74,744</td>
<td>
<a rel="nofollow noopener" href="https://www.sec.gov/Archives/edgar/data/1515673/000120919123030931/xslF345X04/doc4.xml" target="_blank" title="View SEC Filing for John Richard Pinion’s Sell of 2,012 Ultragenyx Pharmaceutical shares on 5/18/2023"><img src="/images/insider-trades-icon-details.svg?v=2" width="27" height="27" alt="View SEC Filing Icon" loading="lazy"></a>
</td>
</tr>
<tr>
<td data-sort="20230504000000">5/4/2023</td>
<td><a href="/ultragenyx-pharmaceutical-inc-stock/karah-herdman-parschauer/">Karah Herdman Parschauer</a></td>
<td>EVP</td>
<td>Sell</td>
<td>4,378</td>
<td>$45.00</td>
<td>$197,010.00</td>
<td>51,982</td>
<td>
<a rel="nofollow noopener" href="https://www.sec.gov/Archives/edgar/data/1515673/000120919123027601/xslF345X04/doc4.xml" target="_blank" title="View SEC Filing for Karah Herdman Parschauer’s Sell of 4,378 Ultragenyx Pharmaceutical shares on 5/4/2023"><img src="/images/insider-trades-icon-details.svg?v=2" width="27" height="27" alt="View SEC Filing Icon" loading="lazy"></a>
</td>
</tr>
<tr>
<td data-sort="20230301000000">3/1/2023</td>
<td><a href="/ultragenyx-pharmaceutical-inc-stock/camille-l-bedrosian/">Camille L. Bedrosian</a></td>
<td>EVP</td>
<td>Sell</td>
<td>3,881</td>
<td>$45.25</td>
<td>$175,615.25</td>
<td>46,720</td>
<td>
<a rel="nofollow noopener" href="https://www.sec.gov/Archives/edgar/data/1515673/000120919123016039/xslF345X03/doc4.xml" target="_blank" title="View SEC Filing for Camille L Bedrosian’s Sell of 3,881 Ultragenyx Pharmaceutical shares on 3/1/2023"><img src="/images/insider-trades-icon-details.svg?v=2" width="27" height="27" alt="View SEC Filing Icon" loading="lazy"></a>
</td>
</tr>
<tr>
<td data-sort="20230301000000">3/1/2023</td>
<td><a href="/ultragenyx-pharmaceutical-inc-stock/dennis-karl-huang/">Dennis Karl Huang</a></td>
<td>Insider</td>
<td>Sell</td>
<td>389</td>
<td>$45.65</td>
<td>$17,757.85</td>
<td>75,314</td>
<td>
<a rel="nofollow noopener" href="https://www.sec.gov/Archives/edgar/data/1515673/000120919123016042/xslF345X03/doc4.xml" target="_blank" title="View SEC Filing for Dennis Karl Huang’s Sell of 389 Ultragenyx Pharmaceutical shares on 3/1/2023"><img src="/images/insider-trades-icon-details.svg?v=2" width="27" height="27" alt="View SEC Filing Icon" loading="lazy"></a>
</td>
</tr>
<tr>
<td data-sort="20230228000000">2/28/2023</td>
<td><a href="/ultragenyx-pharmaceutical-inc-stock/theodore-alan-huizenga/">Theodore Alan Huizenga</a></td>
<td>CAO</td>
<td>Sell</td>
<td>639</td>
<td>$43.40</td>
<td>$27,732.60</td>
<td>15,558</td>
<td>
<a rel="nofollow noopener" href="https://www.sec.gov/Archives/edgar/data/1515673/000120919123016045/xslF345X03/doc4.xml" target="_blank" title="View SEC Filing for Theodore Alan Huizenga’s Sell of 639 Ultragenyx Pharmaceutical shares on 2/28/2023"><img src="/images/insider-trades-icon-details.svg?v=2" width="27" height="27" alt="View SEC Filing Icon" loading="lazy"></a>
</td>
</tr>
<tr>
<td data-sort="20221221000000">12/21/2022</td>
<td><a href="/ultragenyx-pharmaceutical-inc-stock/theodore-alan-huizenga/">Theodore Alan Huizenga</a></td>
<td>CAO</td>
<td>Sell</td>
<td>2,031</td>
<td>$43.96</td>
<td>$89,282.76</td>
<td>16,197</td>
<td>
<a rel="nofollow noopener" href="https://www.sec.gov/Archives/edgar/data/1515673/000120919122062400/xslF345X03/doc4.xml" target="_blank" title="View SEC Filing for Theodore Alan Huizenga’s Sell of 2,031 Ultragenyx Pharmaceutical shares on 12/21/2022"><img src="/images/insider-trades-icon-details.svg?v=2" width="27" height="27" alt="View SEC Filing Icon" loading="lazy"></a>
</td>
</tr>
<tr>
<td data-sort="20221014000000">10/14/2022</td>
<td><a href="/ultragenyx-pharmaceutical-inc-stock/mardi-dier/">Mardi Dier</a></td>
<td>CFO</td>
<td>Sell</td>
<td>1,629</td>
<td>$40.16</td>
<td>$65,420.64</td>
<td>66,695</td>
<td>
<a rel="nofollow noopener" href="https://www.sec.gov/Archives/edgar/data/1515673/000120919122053884/xslF345X03/doc4.xml" target="_blank" title="View SEC Filing for Mardi Dier’s Sell of 1,629 Ultragenyx Pharmaceutical shares on 10/14/2022"><img src="/images/insider-trades-icon-details.svg?v=2" width="27" height="27" alt="View SEC Filing Icon" loading="lazy"></a>
</td>
</tr>
<tr>
<td data-sort="20221012000000">10/12/2022</td>
<td><a href="/ultragenyx-pharmaceutical-inc-stock/mardi-dier/">Mardi Dier</a></td>
<td>CFO</td>
<td>Sell</td>
<td>3,484</td>
<td>$38.22</td>
<td>$133,158.48</td>
<td>68,324</td>
<td>
<a rel="nofollow noopener" href="https://www.sec.gov/Archives/edgar/data/1515673/000120919122053647/xslF345X03/doc4.xml" target="_blank" title="View SEC Filing for Mardi Dier’s Sell of 3,484 Ultragenyx Pharmaceutical shares on 10/12/2022"><img src="/images/insider-trades-icon-details.svg?v=2" width="27" height="27" alt="View SEC Filing Icon" loading="lazy"></a>
</td>
</tr>
<tr>
<td data-sort="20220619000000">6/19/2022</td>
<td><a href="/ultragenyx-pharmaceutical-inc-stock/erik-harris/">Erik Harris</a></td>
<td>EVP</td>
<td>Sell</td>
<td>295</td>
<td>$54.78</td>
<td>$16,160.10</td>
<td>36,160</td>
<td>
<a rel="nofollow noopener" href="https://www.sec.gov/Archives/edgar/data/1515673/000120919122038774/xslF345X03/doc4.xml" target="_blank" title="View SEC Filing for Erik Harris’s Sell of 295 Ultragenyx Pharmaceutical shares on 6/19/2022"><img src="/images/insider-trades-icon-details.svg?v=2" width="27" height="27" alt="View SEC Filing Icon" loading="lazy"></a>
</td>
</tr>
<tr>
<td data-sort="20220416000000">4/16/2022</td>
<td><a href="/ultragenyx-pharmaceutical-inc-stock/theodore-alan-huizenga/">Theodore Alan Huizenga</a></td>
<td>CAO</td>
<td>Sell</td>
<td>132</td>
<td>$84.55</td>
<td>$11,160.60</td>
<td>16,914</td>
<td>
<a rel="nofollow noopener" href="https://www.sec.gov/Archives/edgar/data/1515673/000120919122024699/xslF345X03/doc4.xml" target="_blank" title="View SEC Filing for Theodore Alan Huizenga’s Sell of 132 Ultragenyx Pharmaceutical shares on 4/16/2022"><img src="/images/insider-trades-icon-details.svg?v=2" width="27" height="27" alt="View SEC Filing Icon" loading="lazy"></a>
</td>
</tr>
<tr>
<td data-sort="20220311000000">3/11/2022</td>
<td><a href="/ultragenyx-pharmaceutical-inc-stock/thomas-richard-kassberg/">Thomas Richard Kassberg</a></td>
<td>EVP</td>
<td>Sell</td>
<td>10,281</td>
<td>$67.01</td>
<td>$688,929.81</td>
<td></td>
<td>
<a rel="nofollow noopener" href="https://www.sec.gov/Archives/edgar/data/1303811/000120919122018829/xslF345X03/doc4.xml" target="_blank" title="View SEC Filing for Thomas Richard Kassberg’s Sell of 10,281 Ultragenyx Pharmaceutical shares on 3/11/2022"><img src="/images/insider-trades-icon-details.svg?v=2" width="27" height="27" alt="View SEC Filing Icon" loading="lazy"></a>
</td>
</tr>
<tr>
<td data-sort="20220307000000">3/7/2022</td>
<td><a href="/ultragenyx-pharmaceutical-inc-stock/karah-herdman-parschauer/">Karah Herdman Parschauer</a></td>
<td>EVP</td>
<td>Sell</td>
<td>5,140</td>
<td>$62.95</td>
<td>$323,563.00</td>
<td></td>
<td>
<a rel="nofollow noopener" href="https://www.sec.gov/Archives/edgar/data/1515673/000120919122016931/xslF345X03/doc4.xml" target="_blank" title="View SEC Filing for Karah Herdman Parschauer’s Sell of 5,140 Ultragenyx Pharmaceutical shares on 3/7/2022"><img src="/images/insider-trades-icon-details.svg?v=2" width="27" height="27" alt="View SEC Filing Icon" loading="lazy"></a>
</td>
</tr>
<tr>
<td data-sort="20220301000000">3/1/2022</td>
<td><a href="/ultragenyx-pharmaceutical-inc-stock/erik-harris/">Erik Harris</a></td>
<td>EVP</td>
<td>Sell</td>
<td>2,713</td>
<td>$66.62</td>
<td>$180,740.06</td>
<td></td>
<td>
<a rel="nofollow noopener" href="https://www.sec.gov/Archives/edgar/data/1326969/000120919122015802/xslF345X03/doc4.xml" target="_blank" title="View SEC Filing for Erik Harris’s Sell of 2,713 Ultragenyx Pharmaceutical shares on 3/1/2022"><img src="/images/insider-trades-icon-details.svg?v=2" width="27" height="27" alt="View SEC Filing Icon" loading="lazy"></a>
</td>
</tr>
<tr>
<td data-sort="20220301000000">3/1/2022</td>
<td><a href="/ultragenyx-pharmaceutical-inc-stock/john-richard-pinion/">John Richard Pinion</a></td>
<td>Insider</td>
<td>Sell</td>
<td>4,498</td>
<td>$66.62</td>
<td>$299,656.76</td>
<td></td>
<td>
<a rel="nofollow noopener" href="https://www.sec.gov/Archives/edgar/data/1515673/000120919122015823/xslF345X03/doc4.xml" target="_blank" title="View SEC Filing for John Richard Pinion’s Sell of 4,498 Ultragenyx Pharmaceutical shares on 3/1/2022"><img src="/images/insider-trades-icon-details.svg?v=2" width="27" height="27" alt="View SEC Filing Icon" loading="lazy"></a>
</td>
</tr>
<tr>
<td data-sort="20220130000000">1/30/2022</td>
<td><a href="/ultragenyx-pharmaceutical-inc-stock/camille-l-bedrosian/">Camille L. Bedrosian</a></td>
<td>EVP</td>
<td>Sell</td>
<td>1,657</td>
<td>$66.30</td>
<td>$109,859.10</td>
<td></td>
<td>
<a rel="nofollow noopener" href="https://www.sec.gov/Archives/edgar/data/1326969/000120919122005838/xslF345X03/doc4.xml" target="_blank" title="View SEC Filing for Camille L Bedrosian’s Sell of 1,657 Ultragenyx Pharmaceutical shares on 1/30/2022"><img src="/images/insider-trades-icon-details.svg?v=2" width="27" height="27" alt="View SEC Filing Icon" loading="lazy"></a>
</td>
</tr>
</tbody>
</table>
</div>
<div class="see-more-fade d-none">
<div class="container see-more-fade-inner">
<div class="c-blue see-more-button button">See Full Table</div>
</div>
</div>
</div>
<div class="bg-gray mt-1">
<div class="container">
<a target="_blank" rel="sponsored noopener" style="text-decoration:none;display:inline-block;width:100%;" href="https://www.marketbeat.com/scripts/redirect.aspx?TriggeredCampaignID=11174&UserID=13091940&Placement=NativeDisplay&Source=NativeDisplay&interstitial=1"><div class="row d-sm-flex c-green" style="font-weight:300;line-height:1.3;"><div class="col" style="float:left; -webkit-box-flex: 0; -ms-flex: 0 0 auto; flex: 0 0 auto; width: auto; max-width: none;"><div class="my-1 i-clipped lazy" style="width:153px; height:138px; padding: 0;background:url("https://www.marketbeat.com/logos/articles/20241104130332_unnamed.jpg");background-size:cover;background-position: center;max-width:23vw;max-height:20.75vw;"></div></div><div class="col pb-1" style="-webkit-box-flex: 1; -ms-flex: 1; flex: 1; width: auto; max-width: none;"><div class="pt-1"><div class="green-accent"></div><div class="h2 mt-1">Why buying gold might be a mistake</div><div class="byline-size o-80" style="margin-bottom: 10px;"><span>From DTI | Ad</span></div><div style="clear:both;">Something strange just happened with gold.
With the recent Fed rate cut… My charts are showing a breakout signal I haven't seen in years.
But for now, I'm not rushing to buy gold.
In fact, I'm telling everyone I know to hold off.
Because I believe there’s a far better way to play this upcoming surge.
It's a method that could turn a 1% gold price change into gains like 59%, 118%, or even 228%.
And it doesn't involve buying a single ounce of physical gold or even buying any regular gold stock.
I've been trading gold for nearly 20 years now and this is my #1 recommended approach for trading gold right now.
Most traders miss them completely… But for those who know how to spot them, it takes their trades to a whole new level. </div><div class="a-green a-dark-green mt-1">If you're interested, check out the recording here while the link's still up.</div></div></div></div></a><img
loading="lazy" src="https://www.marketbeat.com/scripts/TriggeredCampaignPixel.ashx?TriggeredCampaignID=11174&Placement=NativeDisplay&Source=NativeDisplay" alt="" height="1" width="1">
</div>
</div>
<div class="container">
<h2 id="sec-filings">SEC Filings (Institutional Ownership Changes) for Ultragenyx Pharmaceutical (NASDAQ:RARE)</h2>
<p>97.67% of Ultragenyx Pharmaceutical stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.</p>
<h3 class="h4">Institutional Buying and Selling by Quarter</h3>
<p class="sr-only">This chart shows the instiutional buying and selling at RARE by year and by quarter.</p>
<a href="#company-description" class="sr-only sr-only-focusable">Skip Institutional Buying and Selling Chart and Table Data</a><a href="#institutional-trading-history" class="sr-only sr-only-focusable">Read Chart Data in Institutional Trading History Table</a>
<div id="SECChart" class="dv-chart" style="height:350px"></div>
</div>
<div class="see-more-section">
<div class="container" id="institutional-trading-history">
<h3>Ultragenyx Pharmaceutical Institutional Trading History</h3>
<table class="tdt sbt">
<thead>
<tr>
<th data-sort="int">Reporting Date</th>
<th data-sort="string">Hedge Fund</th>
<th data-sort="float">Shares Held</th>
<th data-sort="float">Market Value</th>
<th data-sort="float">% of Portfolio</th>
<th data-sort="float">Quarterly Change in Shares</th>
<th data-sort="float">Ownership in Company</th>
<th>Details</th>
</tr>
</thead>
<tbody>
<tr class="even">
<td data-sort="20241226000000">12/26/2024</td>
<td>JPMorgan Chase & Co.</td>
<td>213,210</td>
<td data-sort="11844000">$11.84M</td>
<td>0.0%</td>
<td class="c-red" data-sort="-3.5%">-3.5%</td>
<td>0.231%</td>
<td style="min-width:75px;text-align:center;">
<a rel="nofollow noopener" href="https://www.google.com/search?q=JPMorgan+Chase++Co.+13F SEC" title="Search for JPMorgan Chase & Co.’s 12/26/2024 SEC report of Ultragenyx Pharmaceutical shares on Google" target="_blank"><img src="/images/insider-trades-icon-search.svg?v=2" width="27" height="27" alt="Search for SEC Filing on Google Icon" loading="lazy"></a>
</td>
</tr>
<tr class="odd">
<td data-sort="20241219000000">12/19/2024</td>
<td>Principal Financial Group Inc.</td>
<td>86,440</td>
<td data-sort="4802000">$4.80M</td>
<td>0.0%</td>
<td class="c-green" data-sort="740.0%">+740.0%</td>
<td>0.094%</td>
<td style="min-width:75px;text-align:center;">
<a rel="nofollow noopener" href="https://www.google.com/search?q=Principal+Financial+Group+Inc.+13F SEC" title="Search for Principal Financial Group Inc.’s 12/19/2024 SEC report of Ultragenyx Pharmaceutical shares on Google" target="_blank"><img src="/images/insider-trades-icon-search.svg?v=2" width="27" height="27" alt="Search for SEC Filing on Google Icon" loading="lazy"></a>
</td>
</tr>
<tr class="even">
<td data-sort="20241127000000">11/27/2024</td>
<td>Franklin Resources Inc.</td>
<td>218,903</td>
<td data-sort="12300000">$12.30M</td>
<td>0.0%</td>
<td class="c-red" data-sort="-25.5%">-25.5%</td>
<td>0.237%</td>
<td style="min-width:75px;text-align:center;">
<a rel="nofollow noopener" href="https://www.google.com/search?q=Franklin+Resources+Inc.+13F SEC" title="Search for Franklin Resources Inc.’s 11/27/2024 SEC report of Ultragenyx Pharmaceutical shares on Google" target="_blank"><img src="/images/insider-trades-icon-search.svg?v=2" width="27" height="27" alt="Search for SEC Filing on Google Icon" loading="lazy"></a>
</td>
</tr>
<tr class="odd">
<td data-sort="20241125000000">11/25/2024</td>
<td>Wilmington Savings Fund Society FSB</td>
<td>1,489</td>
<td data-sort="83000">$83K</td>
<td>0.0%</td>
<td data-sort="0">N/A</td>
<td>0.002%</td>
<td style="min-width:75px;text-align:center;">
<a rel="nofollow noopener" href="https://www.google.com/search?q=Wilmington+Savings+Fund+Society+FSB+13F SEC" title="Search for Wilmington Savings Fund Society FSB’s 11/25/2024 SEC report of Ultragenyx Pharmaceutical shares on Google" target="_blank"><img src="/images/insider-trades-icon-search.svg?v=2" width="27" height="27" alt="Search for SEC Filing on Google Icon" loading="lazy"></a>
</td>
</tr>
<tr class="even">
<td data-sort="20241116000000">11/16/2024</td>
<td>Geode Capital Management LLC</td>
<td>1,571,081</td>
<td data-sort="87296000">$87.30M</td>
<td>0.0%</td>
<td class="c-green" data-sort="4.4%">+4.4%</td>
<td>1.701%</td>
<td style="min-width:75px;text-align:center;">
<a rel="nofollow noopener" href="https://www.google.com/search?q=Geode+Capital+Management+LLC+13F SEC" title="Search for Geode Capital Management LLC’s 11/16/2024 SEC report of Ultragenyx Pharmaceutical shares on Google" target="_blank"><img src="/images/insider-trades-icon-search.svg?v=2" width="27" height="27" alt="Search for SEC Filing on Google Icon" loading="lazy"></a>
</td>
</tr>
<tr class="odd">
<td data-sort="20241115000000">11/15/2024</td>
<td>M&T Bank Corp</td>
<td>6,992</td>
<td data-sort="388000">$0.39M</td>
<td>0.0%</td>
<td class="c-green" data-sort="8.1%">+8.1%</td>
<td>0.008%</td>
<td style="min-width:75px;text-align:center;">
<a rel="nofollow noopener" href="https://www.google.com/search?q=MT+Bank+Corp+13F SEC" title="Search for M&T Bank Corp’s 11/15/2024 SEC report of Ultragenyx Pharmaceutical shares on Google" target="_blank"><img src="/images/insider-trades-icon-search.svg?v=2" width="27" height="27" alt="Search for SEC Filing on Google Icon" loading="lazy"></a>
</td>
</tr>
<tr class="even">
<td data-sort="20241115000000">11/15/2024</td>
<td>Frazier Life Sciences Management L.P.</td>
<td>633,715</td>
<td data-sort="35203000">$35.20M</td>
<td>1.4%</td>
<td class="c-green" data-sort="49.1%">+49.1%</td>
<td>0.686%</td>
<td style="min-width:75px;text-align:center;">
<a rel="nofollow noopener" href="https://www.google.com/search?q=Frazier+Life+Sciences+Management+L.P.+13F SEC" title="Search for Frazier Life Sciences Management L.P.’s 11/15/2024 SEC report of Ultragenyx Pharmaceutical shares on Google" target="_blank"><img src="/images/insider-trades-icon-search.svg?v=2" width="27" height="27" alt="Search for SEC Filing on Google Icon" loading="lazy"></a>
</td>
</tr>
<tr class="odd">
<td data-sort="20241115000000">11/15/2024</td>
<td>Barclays PLC</td>
<td>79,546</td>
<td data-sort="4419000">$4.42M</td>
<td>0.0%</td>
<td class="c-red" data-sort="-66.4%">-66.4%</td>
<td>0.086%</td>
<td style="min-width:75px;text-align:center;">
<a rel="nofollow noopener" href="https://www.google.com/search?q=Barclays+PLC+13F SEC" title="Search for Barclays PLC’s 11/15/2024 SEC report of Ultragenyx Pharmaceutical shares on Google" target="_blank"><img src="/images/insider-trades-icon-search.svg?v=2" width="27" height="27" alt="Search for SEC Filing on Google Icon" loading="lazy"></a>
</td>
</tr>
<tr class="even">
<td data-sort="20241115000000">11/15/2024</td>
<td>Public Employees Retirement System of Ohio</td>
<td>32,734</td>
<td data-sort="1818000">$1.82M</td>
<td>0.0%</td>
<td class="c-red" data-sort="-1.6%">-1.6%</td>
<td>0.035%</td>
<td style="min-width:75px;text-align:center;">
<a rel="nofollow noopener" href="https://www.google.com/search?q=Public+Employees+Retirement+System+of+Ohio+13F SEC" title="Search for Public Employees Retirement System of Ohio’s 11/15/2024 SEC report of Ultragenyx Pharmaceutical shares on Google" target="_blank"><img src="/images/insider-trades-icon-search.svg?v=2" width="27" height="27" alt="Search for SEC Filing on Google Icon" loading="lazy"></a>
</td>
</tr>
<tr class="odd">
<td data-sort="20241115000000">11/15/2024</td>
<td>Nomura Asset Management Co. Ltd.</td>
<td>1,669</td>
<td data-sort="93000">$93K</td>
<td>0.0%</td>
<td data-sort="0">N/A</td>
<td>0.002%</td>
<td style="min-width:75px;text-align:center;">
<a rel="nofollow noopener" href="https://www.google.com/search?q=Nomura+Asset+Management+Co.+Ltd.+13F SEC" title="Search for Nomura Asset Management Co. Ltd.’s 11/15/2024 SEC report of Ultragenyx Pharmaceutical shares on Google" target="_blank"><img src="/images/insider-trades-icon-search.svg?v=2" width="27" height="27" alt="Search for SEC Filing on Google Icon" loading="lazy"></a>
</td>
</tr>
<tr class="even">
<td data-sort="20241115000000">11/15/2024</td>
<td>Y Intercept Hong Kong Ltd</td>
<td>19,151</td>
<td data-sort="1064000">$1.06M</td>
<td>0.1%</td>
<td class="c-green" data-sort="193.1%">+193.1%</td>
<td>0.021%</td>
<td style="min-width:75px;text-align:center;">
<a rel="nofollow noopener" href="https://www.google.com/search?q=Y+Intercept+Hong+Kong+Ltd+13F SEC" title="Search for Y Intercept Hong Kong Ltd’s 11/15/2024 SEC report of Ultragenyx Pharmaceutical shares on Google" target="_blank"><img src="/images/insider-trades-icon-search.svg?v=2" width="27" height="27" alt="Search for SEC Filing on Google Icon" loading="lazy"></a>
</td>
</tr>
<tr class="odd">
<td data-sort="20241115000000">11/15/2024</td>
<td>XTX Topco Ltd</td>
<td>14,629</td>
<td data-sort="813000">$0.81M</td>
<td>0.1%</td>
<td class="c-green" data-sort="95.2%">+95.2%</td>
<td>0.016%</td>
<td style="min-width:75px;text-align:center;">
<a rel="nofollow noopener" href="https://www.google.com/search?q=XTX+Topco+Ltd+13F SEC" title="Search for XTX Topco Ltd’s 11/15/2024 SEC report of Ultragenyx Pharmaceutical shares on Google" target="_blank"><img src="/images/insider-trades-icon-search.svg?v=2" width="27" height="27" alt="Search for SEC Filing on Google Icon" loading="lazy"></a>
</td>
</tr>
<tr class="even">
<td data-sort="20241115000000">11/15/2024</td>
<td>Wellington Management Group LLP</td>
<td>4,165,424</td>
<td data-sort="231389000">$231.39M</td>
<td>0.0%</td>
<td class="c-red" data-sort="-8.6%">-8.6%</td>
<td>4.511%</td>
<td style="min-width:75px;text-align:center;">
<a rel="nofollow noopener" href="https://www.google.com/search?q=Wellington+Management+Group+LLP+13F SEC" title="Search for Wellington Management Group LLP’s 11/15/2024 SEC report of Ultragenyx Pharmaceutical shares on Google" target="_blank"><img src="/images/insider-trades-icon-search.svg?v=2" width="27" height="27" alt="Search for SEC Filing on Google Icon" loading="lazy"></a>
</td>
</tr>
<tr class="odd">
<td data-sort="20241115000000">11/15/2024</td>
<td>Two Sigma Advisers LP</td>
<td>987,800</td>
<td data-sort="54872000">$54.87M</td>
<td>0.1%</td>
<td class="c-green" data-sort="123.4%">+123.4%</td>
<td>1.070%</td>
<td style="min-width:75px;text-align:center;">
<a rel="nofollow noopener" href="https://www.google.com/search?q=Two+Sigma+Advisers+LP+13F SEC" title="Search for Two Sigma Advisers LP’s 11/15/2024 SEC report of Ultragenyx Pharmaceutical shares on Google" target="_blank"><img src="/images/insider-trades-icon-search.svg?v=2" width="27" height="27" alt="Search for SEC Filing on Google Icon" loading="lazy"></a>
</td>
</tr>
<tr class="even">
<td data-sort="20241115000000">11/15/2024</td>
<td>Sphera Funds Management LTD.</td>
<td>195,349</td>
<td data-sort="10852000">$10.85M</td>
<td>1.7%</td>
<td class="c-red" data-sort="-33.5%">-33.5%</td>
<td>0.212%</td>
<td style="min-width:75px;text-align:center;">
<a rel="nofollow noopener" href="https://www.google.com/search?q=Sphera+Funds+Management+LTD.+13F SEC" title="Search for Sphera Funds Management LTD.’s 11/15/2024 SEC report of Ultragenyx Pharmaceutical shares on Google" target="_blank"><img src="/images/insider-trades-icon-search.svg?v=2" width="27" height="27" alt="Search for SEC Filing on Google Icon" loading="lazy"></a>
</td>
</tr>
<tr class="odd">
<td data-sort="20241115000000">11/15/2024</td>
<td>State Street Corp</td>
<td>2,664,077</td>
<td data-sort="147989000">$147.99M</td>
<td>0.0%</td>
<td class="c-red" data-sort="-1.2%">-1.2%</td>
<td>2.885%</td>
<td style="min-width:75px;text-align:center;">
<a rel="nofollow noopener" href="https://www.google.com/search?q=State+Street+Corp+13F SEC" title="Search for State Street Corp’s 11/15/2024 SEC report of Ultragenyx Pharmaceutical shares on Google" target="_blank"><img src="/images/insider-trades-icon-search.svg?v=2" width="27" height="27" alt="Search for SEC Filing on Google Icon" loading="lazy"></a>
</td>
</tr>
<tr class="even">
<td data-sort="20241115000000">11/15/2024</td>
<td>Stifel Financial Corp</td>
<td>20,961</td>
<td data-sort="1164000">$1.16M</td>
<td>0.0%</td>
<td class="c-red" data-sort="-4.0%">-4.0%</td>
<td>0.023%</td>
<td style="min-width:75px;text-align:center;">
<a rel="nofollow noopener" href="https://www.google.com/search?q=Stifel+Financial+Corp+13F SEC" title="Search for Stifel Financial Corp’s 11/15/2024 SEC report of Ultragenyx Pharmaceutical shares on Google" target="_blank"><img src="/images/insider-trades-icon-search.svg?v=2" width="27" height="27" alt="Search for SEC Filing on Google Icon" loading="lazy"></a>
</td>
</tr>
<tr class="odd">
<td data-sort="20241115000000">11/15/2024</td>
<td>RTW Investments LP</td>
<td>1,968,002</td>
<td data-sort="109323000">$109.32M</td>
<td>1.6%</td>
<td class="c-red" data-sort="-39.6%">-39.6%</td>
<td>2.131%</td>
<td style="min-width:75px;text-align:center;">
<a rel="nofollow noopener" href="https://www.google.com/search?q=RTW+Investments+LP+13F SEC" title="Search for RTW Investments LP’s 11/15/2024 SEC report of Ultragenyx Pharmaceutical shares on Google" target="_blank"><img src="/images/insider-trades-icon-search.svg?v=2" width="27" height="27" alt="Search for SEC Filing on Google Icon" loading="lazy"></a>
</td>
</tr>
<tr class="even">
<td data-sort="20241115000000">11/15/2024</td>
<td>Point72 DIFC Ltd</td>
<td>14,517</td>
<td data-sort="806000">$0.81M</td>
<td>0.0%</td>
<td class="c-green" data-sort="443.9%">+443.9%</td>
<td>0.016%</td>
<td style="min-width:75px;text-align:center;">
<a rel="nofollow noopener" href="https://www.google.com/search?q=Point72+DIFC+Ltd+13F SEC" title="Search for Point72 DIFC Ltd’s 11/15/2024 SEC report of Ultragenyx Pharmaceutical shares on Google" target="_blank"><img src="/images/insider-trades-icon-search.svg?v=2" width="27" height="27" alt="Search for SEC Filing on Google Icon" loading="lazy"></a>
</td>
</tr>
<tr class="odd">
<td data-sort="20241115000000">11/15/2024</td>
<td>Point72 Asset Management L.P.</td>
<td>653,660</td>
<td data-sort="36311000">$36.31M</td>
<td>0.1%</td>
<td class="c-green" data-sort="35.9%">+35.9%</td>
<td>0.708%</td>
<td style="min-width:75px;text-align:center;">
<a rel="nofollow noopener" href="https://www.google.com/search?q=Point72+Asset+Management+L.P.+13F SEC" title="Search for Point72 Asset Management L.P.’s 11/15/2024 SEC report of Ultragenyx Pharmaceutical shares on Google" target="_blank"><img src="/images/insider-trades-icon-search.svg?v=2" width="27" height="27" alt="Search for SEC Filing on Google Icon" loading="lazy"></a>
</td>
</tr>
<tr class="even">
<td data-sort="20241115000000">11/15/2024</td>
<td>Parkman Healthcare Partners LLC</td>
<td>109,468</td>
<td data-sort="6081000">$6.08M</td>
<td>0.8%</td>
<td class="c-green" data-sort="9.5%">+9.5%</td>
<td>0.119%</td>
<td style="min-width:75px;text-align:center;">
<a rel="nofollow noopener" href="https://www.google.com/search?q=Parkman+Healthcare+Partners+LLC+13F SEC" title="Search for Parkman Healthcare Partners LLC’s 11/15/2024 SEC report of Ultragenyx Pharmaceutical shares on Google" target="_blank"><img src="/images/insider-trades-icon-search.svg?v=2" width="27" height="27" alt="Search for SEC Filing on Google Icon" loading="lazy"></a>
</td>
</tr>
<tr class="odd">
<td data-sort="20241115000000">11/15/2024</td>
<td>Motley Fool Asset Management LLC</td>
<td>141,649</td>
<td data-sort="8005000">$8.01M</td>
<td>0.5%</td>
<td class="c-green" data-sort="0.3%">+0.3%</td>
<td>0.153%</td>
<td style="min-width:75px;text-align:center;">
<a rel="nofollow noopener" href="https://www.google.com/search?q=Motley+Fool+Asset+Management+LLC+13F SEC" title="Search for Motley Fool Asset Management LLC’s 11/15/2024 SEC report of Ultragenyx Pharmaceutical shares on Google" target="_blank"><img src="/images/insider-trades-icon-search.svg?v=2" width="27" height="27" alt="Search for SEC Filing on Google Icon" loading="lazy"></a>
</td>
</tr>
<tr class="even">
<td data-sort="20241115000000">11/15/2024</td>
<td>Motley Fool Wealth Management LLC</td>
<td>168,015</td>
<td data-sort="9333000">$9.33M</td>
<td>0.5%</td>
<td class="c-red" data-sort="-1.4%">-1.4%</td>
<td>0.182%</td>
<td style="min-width:75px;text-align:center;">
<a rel="nofollow noopener" href="https://www.google.com/search?q=Motley+Fool+Wealth+Management+LLC+13F SEC" title="Search for Motley Fool Wealth Management LLC’s 11/15/2024 SEC report of Ultragenyx Pharmaceutical shares on Google" target="_blank"><img src="/images/insider-trades-icon-search.svg?v=2" width="27" height="27" alt="Search for SEC Filing on Google Icon" loading="lazy"></a>
</td>
</tr>
<tr class="odd">
<td data-sort="20241115000000">11/15/2024</td>
<td>NFJ Investment Group LLC</td>
<td>38,131</td>
<td data-sort="2118000">$2.12M</td>
<td>0.1%</td>
<td class="c-red" data-sort="-4.4%">-4.4%</td>
<td>0.041%</td>
<td style="min-width:75px;text-align:center;">
<a rel="nofollow noopener" href="https://www.google.com/search?q=NFJ+Investment+Group+LLC+13F SEC" title="Search for NFJ Investment Group LLC’s 11/15/2024 SEC report of Ultragenyx Pharmaceutical shares on Google" target="_blank"><img src="/images/insider-trades-icon-search.svg?v=2" width="27" height="27" alt="Search for SEC Filing on Google Icon" loading="lazy"></a>
</td>
</tr>
<tr class="even">
<td data-sort="20241115000000">11/15/2024</td>
<td>Ikarian Capital LLC</td>
<td>179,000</td>
<td data-sort="9943000">$9.94M</td>
<td>1.3%</td>
<td data-sort="0">N/A</td>
<td>0.194%</td>
<td style="min-width:75px;text-align:center;">
<a rel="nofollow noopener" href="https://www.google.com/search?q=Ikarian+Capital+LLC+13F SEC" title="Search for Ikarian Capital LLC’s 11/15/2024 SEC report of Ultragenyx Pharmaceutical shares on Google" target="_blank"><img src="/images/insider-trades-icon-search.svg?v=2" width="27" height="27" alt="Search for SEC Filing on Google Icon" loading="lazy"></a>
</td>
</tr>
<tr class="odd">
<td data-sort="20241115000000">11/15/2024</td>
<td>Jacobs Levy Equity Management Inc.</td>
<td>97,960</td>
<td data-sort="5442000">$5.44M</td>
<td>0.0%</td>
<td class="c-red" data-sort="-84.6%">-84.6%</td>
<td>0.106%</td>
<td style="min-width:75px;text-align:center;">
<a rel="nofollow noopener" href="https://www.google.com/search?q=Jacobs+Levy+Equity+Management+Inc.+13F SEC" title="Search for Jacobs Levy Equity Management Inc.’s 11/15/2024 SEC report of Ultragenyx Pharmaceutical shares on Google" target="_blank"><img src="/images/insider-trades-icon-search.svg?v=2" width="27" height="27" alt="Search for SEC Filing on Google Icon" loading="lazy"></a>
</td>
</tr>
<tr class="even">
<td data-sort="20241115000000">11/15/2024</td>
<td>Janus Henderson Group PLC</td>
<td>36,543</td>
<td data-sort="2028000">$2.03M</td>
<td>0.0%</td>
<td class="c-red" data-sort="-49.1%">-49.1%</td>
<td>0.040%</td>
<td style="min-width:75px;text-align:center;">
<a rel="nofollow noopener" href="https://www.google.com/search?q=Janus+Henderson+Group+PLC+13F SEC" title="Search for Janus Henderson Group PLC’s 11/15/2024 SEC report of Ultragenyx Pharmaceutical shares on Google" target="_blank"><img src="/images/insider-trades-icon-search.svg?v=2" width="27" height="27" alt="Search for SEC Filing on Google Icon" loading="lazy"></a>
</td>
</tr>
<tr class="odd">
<td data-sort="20241115000000">11/15/2024</td>
<td>Cinctive Capital Management LP</td>
<td>15,902</td>
<td data-sort="883000">$0.88M</td>
<td>0.0%</td>
<td class="c-red" data-sort="-87.4%">-87.4%</td>
<td>0.017%</td>
<td style="min-width:75px;text-align:center;">
<a rel="nofollow noopener" href="https://www.google.com/search?q=Cinctive+Capital+Management+LP+13F SEC" title="Search for Cinctive Capital Management LP’s 11/15/2024 SEC report of Ultragenyx Pharmaceutical shares on Google" target="_blank"><img src="/images/insider-trades-icon-search.svg?v=2" width="27" height="27" alt="Search for SEC Filing on Google Icon" loading="lazy"></a>
</td>
</tr>
<tr class="even">
<td data-sort="20241115000000">11/15/2024</td>
<td>Benjamin Edwards Inc.</td>
<td>6,084</td>
<td data-sort="338000">$0.34M</td>
<td>0.0%</td>
<td data-sort="0">N/A</td>
<td>0.007%</td>
<td style="min-width:75px;text-align:center;">
<a rel="nofollow noopener" href="https://www.google.com/search?q=Benjamin+Edwards+Inc.+13F SEC" title="Search for Benjamin Edwards Inc.’s 11/15/2024 SEC report of Ultragenyx Pharmaceutical shares on Google" target="_blank"><img src="/images/insider-trades-icon-search.svg?v=2" width="27" height="27" alt="Search for SEC Filing on Google Icon" loading="lazy"></a>
</td>
</tr>
<tr class="odd">
<td data-sort="20241115000000">11/15/2024</td>
<td>Baker BROS. Advisors LP</td>
<td>1,576,114</td>
<td data-sort="87553000">$87.55M</td>
<td>0.9%</td>
<td class="c-green" data-sort="7.5%">+7.5%</td>
<td>1.707%</td>
<td style="min-width:75px;text-align:center;">
<a rel="nofollow noopener" href="https://www.google.com/search?q=Baker+BROS.+Advisors+LP+13F SEC" title="Search for Baker BROS. Advisors LP’s 11/15/2024 SEC report of Ultragenyx Pharmaceutical shares on Google" target="_blank"><img src="/images/insider-trades-icon-search.svg?v=2" width="27" height="27" alt="Search for SEC Filing on Google Icon" loading="lazy"></a>
</td>
</tr>
<tr class="even">
<td data-sort="20241115000000">11/15/2024</td>
<td>Bamco Inc. NY</td>
<td>48,000</td>
<td data-sort="2666000">$2.67M</td>
<td>0.0%</td>
<td data-sort="0">N/A</td>
<td>0.052%</td>
<td style="min-width:75px;text-align:center;">
<a rel="nofollow noopener" href="https://www.google.com/search?q=Bamco+Inc.+NY+13F SEC" title="Search for Bamco Inc. NY’s 11/15/2024 SEC report of Ultragenyx Pharmaceutical shares on Google" target="_blank"><img src="/images/insider-trades-icon-search.svg?v=2" width="27" height="27" alt="Search for SEC Filing on Google Icon" loading="lazy"></a>
</td>
</tr>
<tr class="odd">
<td data-sort="20241115000000">11/15/2024</td>
<td>Point72 Hong Kong Ltd</td>
<td>10,020</td>
<td data-sort="557000">$0.56M</td>
<td>0.0%</td>
<td data-sort="0">N/A</td>
<td>0.011%</td>
<td style="min-width:75px;text-align:center;">
<a rel="nofollow noopener" href="https://www.google.com/search?q=Point72+Hong+Kong+Ltd+13F SEC" title="Search for Point72 Hong Kong Ltd’s 11/15/2024 SEC report of Ultragenyx Pharmaceutical shares on Google" target="_blank"><img src="/images/insider-trades-icon-search.svg?v=2" width="27" height="27" alt="Search for SEC Filing on Google Icon" loading="lazy"></a>
</td>
</tr>
<tr class="even">
<td data-sort="20241115000000">11/15/2024</td>
<td>Erste Asset Management GmbH</td>
<td>15,010</td>
<td data-sort="817000">$0.82M</td>
<td>0.0%</td>
<td data-sort="0">N/A</td>
<td>0.016%</td>
<td style="min-width:75px;text-align:center;">
<a rel="nofollow noopener" href="https://www.google.com/search?q=Erste+Asset+Management+GmbH+13F SEC" title="Search for Erste Asset Management GmbH’s 11/15/2024 SEC report of Ultragenyx Pharmaceutical shares on Google" target="_blank"><img src="/images/insider-trades-icon-search.svg?v=2" width="27" height="27" alt="Search for SEC Filing on Google Icon" loading="lazy"></a>
</td>
</tr>
<tr class="odd">
<td data-sort="20241115000000">11/15/2024</td>
<td>True Wealth Design LLC</td>
<td>778</td>
<td data-sort="43000">$43K</td>
<td>0.0%</td>
<td data-sort="0">N/A</td>
<td>0.001%</td>
<td style="min-width:75px;text-align:center;">
<a rel="nofollow noopener" href="https://www.google.com/search?q=True+Wealth+Design+LLC+13F SEC" title="Search for True Wealth Design LLC’s 11/15/2024 SEC report of Ultragenyx Pharmaceutical shares on Google" target="_blank"><img src="/images/insider-trades-icon-search.svg?v=2" width="27" height="27" alt="Search for SEC Filing on Google Icon" loading="lazy"></a>
</td>
</tr>
<tr class="even">
<td data-sort="20241114000000">11/14/2024</td>
<td>PDT Partners LLC</td>
<td>66,193</td>
<td data-sort="3677000">$3.68M</td>
<td>0.3%</td>
<td class="c-green" data-sort="26.1%">+26.1%</td>
<td>0.072%</td>
<td style="min-width:75px;text-align:center;">
<a rel="nofollow noopener" href="https://www.google.com/search?q=PDT+Partners+LLC+13F SEC" title="Search for PDT Partners LLC’s 11/14/2024 SEC report of Ultragenyx Pharmaceutical shares on Google" target="_blank"><img src="/images/insider-trades-icon-search.svg?v=2" width="27" height="27" alt="Search for SEC Filing on Google Icon" loading="lazy"></a>
</td>
</tr>
<tr class="odd">
<td data-sort="20241114000000">11/14/2024</td>
<td>Fred Alger Management LLC</td>
<td>536,298</td>
<td data-sort="29791000">$29.79M</td>
<td>0.1%</td>
<td class="c-red" data-sort="-2.3%">-2.3%</td>
<td>0.581%</td>
<td style="min-width:75px;text-align:center;">
<a rel="nofollow noopener" href="https://www.google.com/search?q=Fred+Alger+Management+LLC+13F SEC" title="Search for Fred Alger Management LLC’s 11/14/2024 SEC report of Ultragenyx Pharmaceutical shares on Google" target="_blank"><img src="/images/insider-trades-icon-search.svg?v=2" width="27" height="27" alt="Search for SEC Filing on Google Icon" loading="lazy"></a>
</td>
</tr>
<tr class="even">
<td data-sort="20241114000000">11/14/2024</td>
<td>Verition Fund Management LLC</td>
<td>77,306</td>
<td data-sort="4294000">$4.29M</td>
<td>0.0%</td>
<td class="c-red" data-sort="-43.7%">-43.7%</td>
<td>0.084%</td>
<td style="min-width:75px;text-align:center;">
<a rel="nofollow noopener" href="https://www.google.com/search?q=Verition+Fund+Management+LLC+13F SEC" title="Search for Verition Fund Management LLC’s 11/14/2024 SEC report of Ultragenyx Pharmaceutical shares on Google" target="_blank"><img src="/images/insider-trades-icon-search.svg?v=2" width="27" height="27" alt="Search for SEC Filing on Google Icon" loading="lazy"></a>
</td>
</tr>
<tr class="odd">
<td data-sort="20241114000000">11/14/2024</td>
<td>Captrust Financial Advisors</td>
<td>11,428</td>
<td data-sort="635000">$0.64M</td>
<td>0.0%</td>
<td class="c-green" data-sort="129.3%">+129.3%</td>
<td>0.012%</td>
<td style="min-width:75px;text-align:center;">
<a rel="nofollow noopener" href="https://www.google.com/search?q=Captrust+Financial+Advisors+13F SEC" title="Search for Captrust Financial Advisors’s 11/14/2024 SEC report of Ultragenyx Pharmaceutical shares on Google" target="_blank"><img src="/images/insider-trades-icon-search.svg?v=2" width="27" height="27" alt="Search for SEC Filing on Google Icon" loading="lazy"></a>
</td>
</tr>
<tr class="even">
<td data-sort="20241114000000">11/14/2024</td>
<td>Vestal Point Capital LP</td>
<td>750,000</td>
<td data-sort="41662000">$41.66M</td>
<td>3.2%</td>
<td class="c-red" data-sort="-58.3%">-58.3%</td>
<td>0.812%</td>
<td style="min-width:75px;text-align:center;">
<a rel="nofollow noopener" href="https://www.google.com/search?q=Vestal+Point+Capital+LP+13F SEC" title="Search for Vestal Point Capital LP’s 11/14/2024 SEC report of Ultragenyx Pharmaceutical shares on Google" target="_blank"><img src="/images/insider-trades-icon-search.svg?v=2" width="27" height="27" alt="Search for SEC Filing on Google Icon" loading="lazy"></a>
</td>
</tr>
<tr class="odd">
<td data-sort="20241114000000">11/14/2024</td>
<td>Capstone Investment Advisors LLC</td>
<td>13,089</td>
<td data-sort="727000">$0.73M</td>
<td>0.0%</td>
<td data-sort="0">N/A</td>
<td>0.014%</td>
<td style="min-width:75px;text-align:center;">
<a rel="nofollow noopener" href="https://www.google.com/search?q=Capstone+Investment+Advisors+LLC+13F SEC" title="Search for Capstone Investment Advisors LLC’s 11/14/2024 SEC report of Ultragenyx Pharmaceutical shares on Google" target="_blank"><img src="/images/insider-trades-icon-search.svg?v=2" width="27" height="27" alt="Search for SEC Filing on Google Icon" loading="lazy"></a>
</td>
</tr>
<tr class="even">
<td data-sort="20241114000000">11/14/2024</td>
<td>Suvretta Capital Management LLC</td>
<td>1,151,314</td>
<td data-sort="63955000">$63.96M</td>
<td>2.0%</td>
<td class="c-red" data-sort="-44.1%">-44.1%</td>
<td>1.247%</td>
<td style="min-width:75px;text-align:center;">
<a rel="nofollow noopener" href="https://www.google.com/search?q=Suvretta+Capital+Management+LLC+13F SEC" title="Search for Suvretta Capital Management LLC’s 11/14/2024 SEC report of Ultragenyx Pharmaceutical shares on Google" target="_blank"><img src="/images/insider-trades-icon-search.svg?v=2" width="27" height="27" alt="Search for SEC Filing on Google Icon" loading="lazy"></a>
</td>
</tr>
<tr class="odd">
<td data-sort="20241114000000">11/14/2024</td>
<td>Hantz Financial Services Inc.</td>
<td>3,499</td>
<td data-sort="194000">$0.19M</td>
<td>0.0%</td>
<td data-sort="0">N/A</td>
<td>0.004%</td>
<td style="min-width:75px;text-align:center;">
<a rel="nofollow noopener" href="https://www.google.com/search?q=Hantz+Financial+Services+Inc.+13F SEC" title="Search for Hantz Financial Services Inc.’s 11/14/2024 SEC report of Ultragenyx Pharmaceutical shares on Google" target="_blank"><img src="/images/insider-trades-icon-search.svg?v=2" width="27" height="27" alt="Search for SEC Filing on Google Icon" loading="lazy"></a>
</td>
</tr>
<tr class="even">
<td data-sort="20241114000000">11/14/2024</td>
<td>Alkeon Capital Management LLC</td>
<td>3,011,716</td>
<td data-sort="167301000">$167.30M</td>
<td>0.3%</td>
<td class="c-green" data-sort="34.3%">+34.3%</td>
<td>3.261%</td>
<td style="min-width:75px;text-align:center;">
<a rel="nofollow noopener" href="https://www.google.com/search?q=Alkeon+Capital+Management+LLC+13F SEC" title="Search for Alkeon Capital Management LLC’s 11/14/2024 SEC report of Ultragenyx Pharmaceutical shares on Google" target="_blank"><img src="/images/insider-trades-icon-search.svg?v=2" width="27" height="27" alt="Search for SEC Filing on Google Icon" loading="lazy"></a>
</td>
</tr>
<tr class="odd">
<td data-sort="20241114000000">11/14/2024</td>
<td>UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC</td>
<td>177,756</td>
<td data-sort="9874000">$9.87M</td>
<td>0.0%</td>
<td class="c-green" data-sort="0.5%">+0.5%</td>
<td>0.192%</td>
<td style="min-width:75px;text-align:center;">
<a rel="nofollow noopener" href="https://www.google.com/search?q=UBS+AM+a+distinct+business+unit+of+UBS+ASSET+MANAGEMENT+AMERICAS+LLC+13F SEC" title="Search for UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC’s 11/14/2024 SEC report of Ultragenyx Pharmaceutical shares on Google" target="_blank"><img src="/images/insider-trades-icon-search.svg?v=2" width="27" height="27" alt="Search for SEC Filing on Google Icon" loading="lazy"></a>
</td>
</tr>
<tr class="even">
<td data-sort="20241114000000">11/14/2024</td>
<td>Acuta Capital Partners LLC</td>
<td>25,100</td>
<td data-sort="1394000">$1.39M</td>
<td>1.1%</td>
<td data-sort="0">N/A</td>
<td>0.027%</td>
<td style="min-width:75px;text-align:center;">
<a rel="nofollow noopener" href="https://www.google.com/search?q=Acuta+Capital+Partners+LLC+13F SEC" title="Search for Acuta Capital Partners LLC’s 11/14/2024 SEC report of Ultragenyx Pharmaceutical shares on Google" target="_blank"><img src="/images/insider-trades-icon-search.svg?v=2" width="27" height="27" alt="Search for SEC Filing on Google Icon" loading="lazy"></a>
</td>
</tr>
<tr class="odd">
<td data-sort="20241113000000">11/13/2024</td>
<td>BNP Paribas Financial Markets</td>
<td>28,831</td>
<td data-sort="1602000">$1.60M</td>
<td>0.0%</td>
<td class="c-red" data-sort="-57.3%">-57.3%</td>
<td>0.031%</td>
<td style="min-width:75px;text-align:center;">
<a rel="nofollow noopener" href="https://www.google.com/search?q=BNP+Paribas+Financial+Markets+13F SEC" title="Search for BNP Paribas Financial Markets’s 11/13/2024 SEC report of Ultragenyx Pharmaceutical shares on Google" target="_blank"><img src="/images/insider-trades-icon-search.svg?v=2" width="27" height="27" alt="Search for SEC Filing on Google Icon" loading="lazy"></a>
</td>
</tr>
<tr class="even">
<td data-sort="20241113000000">11/13/2024</td>
<td>FMR LLC</td>
<td>637,821</td>
<td data-sort="35431000">$35.43M</td>
<td>0.0%</td>
<td class="c-red" data-sort="-1.5%">-1.5%</td>
<td>0.691%</td>
<td style="min-width:75px;text-align:center;">
<a rel="nofollow noopener" href="https://www.google.com/search?q=FMR+LLC+13F SEC" title="Search for FMR LLC’s 11/13/2024 SEC report of Ultragenyx Pharmaceutical shares on Google" target="_blank"><img src="/images/insider-trades-icon-search.svg?v=2" width="27" height="27" alt="Search for SEC Filing on Google Icon" loading="lazy"></a>
</td>
</tr>
<tr class="odd">
<td data-sort="20241113000000">11/13/2024</td>
<td>The Manufacturers Life Insurance Company</td>
<td>238,055</td>
<td data-sort="13224000">$13.22M</td>
<td>0.0%</td>
<td class="c-red" data-sort="-3.7%">-3.7%</td>
<td>0.258%</td>
<td style="min-width:75px;text-align:center;">
<a rel="nofollow noopener" href="https://www.google.com/search?q=The+Manufacturers+Life+Insurance+Company+13F SEC" title="Search for The Manufacturers Life Insurance Company’s 11/13/2024 SEC report of Ultragenyx Pharmaceutical shares on Google" target="_blank"><img src="/images/insider-trades-icon-search.svg?v=2" width="27" height="27" alt="Search for SEC Filing on Google Icon" loading="lazy"></a>
</td>
</tr>
<tr class="even">
<td data-sort="20241112000000">11/12/2024</td>
<td>Pitcairn Co.</td>
<td>10,584</td>
<td data-sort="588000">$0.59M</td>
<td>0.0%</td>
<td class="c-red" data-sort="-12.1%">-12.1%</td>
<td>0.011%</td>
<td style="min-width:75px;text-align:center;">
<a rel="nofollow noopener" href="https://www.google.com/search?q=Pitcairn+Co.+13F SEC" title="Search for Pitcairn Co.’s 11/12/2024 SEC report of Ultragenyx Pharmaceutical shares on Google" target="_blank"><img src="/images/insider-trades-icon-search.svg?v=2" width="27" height="27" alt="Search for SEC Filing on Google Icon" loading="lazy"></a>
</td>
</tr>
<tr class="odd">
<td data-sort="20241112000000">11/12/2024</td>
<td>Algert Global LLC</td>
<td>73,902</td>
<td data-sort="4105000">$4.11M</td>
<td>0.1%</td>
<td class="c-green" data-sort="46.9%">+46.9%</td>
<td>0.080%</td>
<td style="min-width:75px;text-align:center;">
<a rel="nofollow noopener" href="https://www.google.com/search?q=Algert+Global+LLC+13F SEC" title="Search for Algert Global LLC’s 11/12/2024 SEC report of Ultragenyx Pharmaceutical shares on Google" target="_blank"><img src="/images/insider-trades-icon-search.svg?v=2" width="27" height="27" alt="Search for SEC Filing on Google Icon" loading="lazy"></a>
</td>
</tr>
<tr class="even">
<td data-sort="20241112000000">11/12/2024</td>
<td>Cerity Partners LLC</td>
<td>31,919</td>
<td data-sort="1773000">$1.77M</td>
<td>0.0%</td>
<td data-sort="0">N/A</td>
<td>0.035%</td>
<td style="min-width:75px;text-align:center;">
<a rel="nofollow noopener" href="https://www.google.com/search?q=Cerity+Partners+LLC+13F SEC" title="Search for Cerity Partners LLC’s 11/12/2024 SEC report of Ultragenyx Pharmaceutical shares on Google" target="_blank"><img src="/images/insider-trades-icon-search.svg?v=2" width="27" height="27" alt="Search for SEC Filing on Google Icon" loading="lazy"></a>
</td>
</tr>
<tr class="odd">
<td data-sort="20241112000000">11/12/2024</td>
<td>Charles Schwab Investment Management Inc.</td>
<td>594,521</td>
<td data-sort="33026000">$33.03M</td>
<td>0.0%</td>
<td class="c-green" data-sort="10.6%">+10.6%</td>
<td>0.644%</td>
<td style="min-width:75px;text-align:center;">
<a rel="nofollow noopener" href="https://www.google.com/search?q=Charles+Schwab+Investment+Management+Inc.+13F SEC" title="Search for Charles Schwab Investment Management Inc.’s 11/12/2024 SEC report of Ultragenyx Pharmaceutical shares on Google" target="_blank"><img src="/images/insider-trades-icon-search.svg?v=2" width="27" height="27" alt="Search for SEC Filing on Google Icon" loading="lazy"></a>
</td>
</tr>
<tr class="even">
<td data-sort="20241112000000">11/12/2024</td>
<td>Massachusetts Financial Services Co. MA</td>
<td>542,373</td>
<td data-sort="30129000">$30.13M</td>
<td>0.0%</td>
<td class="c-green" data-sort="46.5%">+46.5%</td>
<td>0.587%</td>
<td style="min-width:75px;text-align:center;">
<a rel="nofollow noopener" href="https://www.google.com/search?q=Massachusetts+Financial+Services+Co.+MA+13F SEC" title="Search for Massachusetts Financial Services Co. MA’s 11/12/2024 SEC report of Ultragenyx Pharmaceutical shares on Google" target="_blank"><img src="/images/insider-trades-icon-search.svg?v=2" width="27" height="27" alt="Search for SEC Filing on Google Icon" loading="lazy"></a>
</td>
</tr>
<tr class="odd">
<td data-sort="20241108000000">11/8/2024</td>
<td>BNP PARIBAS ASSET MANAGEMENT Holding S.A.</td>
<td>724,182</td>
<td data-sort="40228000">$40.23M</td>
<td>0.1%</td>
<td class="c-red" data-sort="-12.8%">-12.8%</td>
<td>0.786%</td>
<td style="min-width:75px;text-align:center;">
<a rel="nofollow noopener" href="https://www.google.com/search?q=BNP+PARIBAS+ASSET+MANAGEMENT+Holding+S.A.+13F SEC" title="Search for BNP PARIBAS ASSET MANAGEMENT Holding S.A.’s 11/8/2024 SEC report of Ultragenyx Pharmaceutical shares on Google" target="_blank"><img src="/images/insider-trades-icon-search.svg?v=2" width="27" height="27" alt="Search for SEC Filing on Google Icon" loading="lazy"></a>
</td>
</tr>
<tr class="even">
<td data-sort="20241108000000">11/8/2024</td>
<td>Connor Clark & Lunn Investment Management Ltd.</td>
<td>75,265</td>
<td data-sort="4181000">$4.18M</td>
<td>0.0%</td>
<td class="c-red" data-sort="-53.8%">-53.8%</td>
<td>0.082%</td>
<td style="min-width:75px;text-align:center;">
<a rel="nofollow noopener" href="https://www.google.com/search?q=Connor+Clark++Lunn+Investment+Management+Ltd.+13F SEC" title="Search for Connor Clark & Lunn Investment Management Ltd.’s 11/8/2024 SEC report of Ultragenyx Pharmaceutical shares on Google" target="_blank"><img src="/images/insider-trades-icon-search.svg?v=2" width="27" height="27" alt="Search for SEC Filing on Google Icon" loading="lazy"></a>
</td>
</tr>
<tr class="odd">
<td data-sort="20241108000000">11/8/2024</td>
<td>B. Metzler seel. Sohn & Co. Holding AG</td>
<td>23,817</td>
<td data-sort="1323000">$1.32M</td>
<td>0.0%</td>
<td data-sort="0">N/A</td>
<td>0.026%</td>
<td style="min-width:75px;text-align:center;">
<a rel="nofollow noopener" href="https://www.google.com/search?q=B.+Metzler+seel.+Sohn++Co.+Holding+AG+13F SEC" title="Search for B. Metzler seel. Sohn & Co. Holding AG’s 11/8/2024 SEC report of Ultragenyx Pharmaceutical shares on Google" target="_blank"><img src="/images/insider-trades-icon-search.svg?v=2" width="27" height="27" alt="Search for SEC Filing on Google Icon" loading="lazy"></a>
</td>
</tr>
<tr class="even">
<td data-sort="20241107000000">11/7/2024</td>
<td>Quest Partners LLC</td>
<td>2,145</td>
<td data-sort="119000">$0.12M</td>
<td>0.0%</td>
<td data-sort="0">N/A</td>
<td>0.002%</td>
<td style="min-width:75px;text-align:center;">
<a rel="nofollow noopener" href="https://www.google.com/search?q=Quest+Partners+LLC+13F SEC" title="Search for Quest Partners LLC’s 11/7/2024 SEC report of Ultragenyx Pharmaceutical shares on Google" target="_blank"><img src="/images/insider-trades-icon-search.svg?v=2" width="27" height="27" alt="Search for SEC Filing on Google Icon" loading="lazy"></a>
</td>
</tr>
<tr class="odd">
<td data-sort="20241107000000">11/7/2024</td>
<td>Swiss National Bank</td>
<td>159,152</td>
<td data-sort="8841000">$8.84M</td>
<td>0.0%</td>
<td class="c-green" data-sort="9.1%">+9.1%</td>
<td>0.173%</td>
<td style="min-width:75px;text-align:center;">
<a rel="nofollow noopener" href="https://www.google.com/search?q=Swiss+National+Bank+13F SEC" title="Search for Swiss National Bank’s 11/7/2024 SEC report of Ultragenyx Pharmaceutical shares on Google" target="_blank"><img src="/images/insider-trades-icon-search.svg?v=2" width="27" height="27" alt="Search for SEC Filing on Google Icon" loading="lazy"></a>
</td>
</tr>
<tr class="even">
<td data-sort="20241106000000">11/6/2024</td>
<td>Mutual of America Capital Management LLC</td>
<td>5,780</td>
<td data-sort="321000">$0.32M</td>
<td>0.0%</td>
<td data-sort="0">N/A</td>
<td>0.006%</td>
<td style="min-width:75px;text-align:center;">
<a rel="nofollow noopener" href="https://www.google.com/search?q=Mutual+of+America+Capital+Management+LLC+13F SEC" title="Search for Mutual of America Capital Management LLC’s 11/6/2024 SEC report of Ultragenyx Pharmaceutical shares on Google" target="_blank"><img src="/images/insider-trades-icon-search.svg?v=2" width="27" height="27" alt="Search for SEC Filing on Google Icon" loading="lazy"></a>
</td>
</tr>
<tr class="odd">
<td data-sort="20241106000000">11/6/2024</td>
<td>Natixis Advisors LLC</td>
<td>52,562</td>
<td data-sort="2920000">$2.92M</td>
<td>0.0%</td>
<td class="c-green" data-sort="290.0%">+290.0%</td>
<td>0.057%</td>
<td style="min-width:75px;text-align:center;">
<a rel="nofollow noopener" href="https://www.google.com/search?q=Natixis+Advisors+LLC+13F SEC" title="Search for Natixis Advisors LLC’s 11/6/2024 SEC report of Ultragenyx Pharmaceutical shares on Google" target="_blank"><img src="/images/insider-trades-icon-search.svg?v=2" width="27" height="27" alt="Search for SEC Filing on Google Icon" loading="lazy"></a>
</td>
</tr>
<tr class="even">
<td data-sort="20241106000000">11/6/2024</td>
<td>KBC Group NV</td>
<td>2,568</td>
<td data-sort="143000">$0.14M</td>
<td>0.0%</td>
<td class="c-green" data-sort="24.5%">+24.5%</td>
<td>0.003%</td>
<td style="min-width:75px;text-align:center;">
<a rel="nofollow noopener" href="https://www.google.com/search?q=KBC+Group+NV+13F SEC" title="Search for KBC Group NV’s 11/6/2024 SEC report of Ultragenyx Pharmaceutical shares on Google" target="_blank"><img src="/images/insider-trades-icon-search.svg?v=2" width="27" height="27" alt="Search for SEC Filing on Google Icon" loading="lazy"></a>
</td>
</tr>
<tr class="odd">
<td data-sort="20241106000000">11/6/2024</td>
<td>Pier 88 Investment Partners LLC</td>
<td>22,540</td>
<td data-sort="1252000">$1.25M</td>
<td>0.3%</td>
<td class="c-red" data-sort="-13.2%">-13.2%</td>
<td>0.024%</td>
<td style="min-width:75px;text-align:center;">
<a rel="nofollow noopener" href="https://www.google.com/search?q=Pier+88+Investment+Partners+LLC+13F SEC" title="Search for Pier 88 Investment Partners LLC’s 11/6/2024 SEC report of Ultragenyx Pharmaceutical shares on Google" target="_blank"><img src="/images/insider-trades-icon-search.svg?v=2" width="27" height="27" alt="Search for SEC Filing on Google Icon" loading="lazy"></a>
</td>
</tr>
<tr class="even">
<td data-sort="20241106000000">11/6/2024</td>
<td>Angeles Investment Advisors LLC</td>
<td>5,911</td>
<td data-sort="328000">$0.33M</td>
<td>0.0%</td>
<td class="c-red" data-sort="-11.0%">-11.0%</td>
<td>0.006%</td>
<td style="min-width:75px;text-align:center;">
<a rel="nofollow noopener" href="https://www.google.com/search?q=Angeles+Investment+Advisors+LLC+13F SEC" title="Search for Angeles Investment Advisors LLC’s 11/6/2024 SEC report of Ultragenyx Pharmaceutical shares on Google" target="_blank"><img src="/images/insider-trades-icon-search.svg?v=2" width="27" height="27" alt="Search for SEC Filing on Google Icon" loading="lazy"></a>
</td>
</tr>
<tr class="odd">
<td data-sort="20241105000000">11/5/2024</td>
<td>Victory Capital Management Inc.</td>
<td>10,948</td>
<td data-sort="608000">$0.61M</td>
<td>0.0%</td>
<td class="c-green" data-sort="8.8%">+8.8%</td>
<td>0.012%</td>
<td style="min-width:75px;text-align:center;">
<a rel="nofollow noopener" href="https://www.google.com/search?q=Victory+Capital+Management+Inc.+13F SEC" title="Search for Victory Capital Management Inc.’s 11/5/2024 SEC report of Ultragenyx Pharmaceutical shares on Google" target="_blank"><img src="/images/insider-trades-icon-search.svg?v=2" width="27" height="27" alt="Search for SEC Filing on Google Icon" loading="lazy"></a>
</td>
</tr>
<tr class="even">
<td data-sort="20241105000000">11/5/2024</td>
<td>GSA Capital Partners LLP</td>
<td>11,508</td>
<td data-sort="639000">$0.64M</td>
<td>0.0%</td>
<td class="c-red" data-sort="-26.1%">-26.1%</td>
<td>0.012%</td>
<td style="min-width:75px;text-align:center;">
<a rel="nofollow noopener" href="https://www.google.com/search?q=GSA+Capital+Partners+LLP+13F SEC" title="Search for GSA Capital Partners LLP’s 11/5/2024 SEC report of Ultragenyx Pharmaceutical shares on Google" target="_blank"><img src="/images/insider-trades-icon-search.svg?v=2" width="27" height="27" alt="Search for SEC Filing on Google Icon" loading="lazy"></a>
</td>
</tr>
<tr class="odd">
<td data-sort="20241105000000">11/5/2024</td>
<td>WCM Investment Management LLC</td>
<td>145,349</td>
<td data-sort="7911000">$7.91M</td>
<td>0.0%</td>
<td class="c-red" data-sort="-6.0%">-6.0%</td>
<td>0.158%</td>
<td style="min-width:75px;text-align:center;">
<a rel="nofollow noopener" href="https://www.google.com/search?q=WCM+Investment+Management+LLC+13F SEC" title="Search for WCM Investment Management LLC’s 11/5/2024 SEC report of Ultragenyx Pharmaceutical shares on Google" target="_blank"><img src="/images/insider-trades-icon-search.svg?v=2" width="27" height="27" alt="Search for SEC Filing on Google Icon" loading="lazy"></a>
</td>
</tr>
<tr class="even">
<td data-sort="20241104000000">11/4/2024</td>
<td>State of New Jersey Common Pension Fund D</td>
<td>34,769</td>
<td data-sort="1931000">$1.93M</td>
<td>0.0%</td>
<td class="c-red" data-sort="-28.7%">-28.7%</td>
<td>0.038%</td>
<td style="min-width:75px;text-align:center;">
<a rel="nofollow noopener" href="https://www.google.com/search?q=State+of+New+Jersey+Common+Pension+Fund+D+13F SEC" title="Search for State of New Jersey Common Pension Fund D’s 11/4/2024 SEC report of Ultragenyx Pharmaceutical shares on Google" target="_blank"><img src="/images/insider-trades-icon-search.svg?v=2" width="27" height="27" alt="Search for SEC Filing on Google Icon" loading="lazy"></a>
</td>
</tr>
<tr class="odd">
<td data-sort="20241102000000">11/2/2024</td>
<td>Privium Fund Management B.V.</td>
<td>242,512</td>
<td data-sort="13472000">$13.47M</td>
<td>3.4%</td>
<td class="c-red" data-sort="-3.6%">-3.6%</td>
<td>0.263%</td>
<td style="min-width:75px;text-align:center;">
<a rel="nofollow noopener" href="https://www.google.com/search?q=Privium+Fund+Management+B.V.+13F SEC" title="Search for Privium Fund Management B.V.’s 11/2/2024 SEC report of Ultragenyx Pharmaceutical shares on Google" target="_blank"><img src="/images/insider-trades-icon-search.svg?v=2" width="27" height="27" alt="Search for SEC Filing on Google Icon" loading="lazy"></a>
</td>
</tr>
<tr class="even">
<td data-sort="20241101000000">11/1/2024</td>
<td>Atria Investments Inc</td>
<td>4,836</td>
<td data-sort="269000">$0.27M</td>
<td>0.0%</td>
<td data-sort="0">N/A</td>
<td>0.005%</td>
<td style="min-width:75px;text-align:center;">
<a rel="nofollow noopener" href="https://www.google.com/search?q=Atria+Investments+Inc+13F SEC" title="Search for Atria Investments Inc’s 11/1/2024 SEC report of Ultragenyx Pharmaceutical shares on Google" target="_blank"><img src="/images/insider-trades-icon-search.svg?v=2" width="27" height="27" alt="Search for SEC Filing on Google Icon" loading="lazy"></a>
</td>
</tr>
<tr class="odd">
<td data-sort="20241101000000">11/1/2024</td>
<td>Capital Performance Advisors LLP</td>
<td>1,934</td>
<td data-sort="107000">$0.11M</td>
<td>0.0%</td>
<td data-sort="0">N/A</td>
<td>0.002%</td>
<td style="min-width:75px;text-align:center;">
<a rel="nofollow noopener" href="https://www.google.com/search?q=Capital+Performance+Advisors+LLP+13F SEC" title="Search for Capital Performance Advisors LLP’s 11/1/2024 SEC report of Ultragenyx Pharmaceutical shares on Google" target="_blank"><img src="/images/insider-trades-icon-search.svg?v=2" width="27" height="27" alt="Search for SEC Filing on Google Icon" loading="lazy"></a>
</td>
</tr>
<tr class="even">
<td data-sort="20241031000000">10/31/2024</td>
<td>Principal Financial Group Inc.</td>
<td>86,440</td>
<td data-sort="4802000">$4.80M</td>
<td>0.0%</td>
<td class="c-green" data-sort="740.0%">+740.0%</td>
<td>0.104%</td>
<td style="min-width:75px;text-align:center;">
<a rel="nofollow noopener" href="https://www.google.com/search?q=Principal+Financial+Group+Inc.+13F SEC" title="Search for Principal Financial Group Inc.’s 10/31/2024 SEC report of Ultragenyx Pharmaceutical shares on Google" target="_blank"><img src="/images/insider-trades-icon-search.svg?v=2" width="27" height="27" alt="Search for SEC Filing on Google Icon" loading="lazy"></a>
</td>
</tr>
<tr class="odd">
<td data-sort="20241029000000">10/29/2024</td>
<td>Emerald Advisers LLC</td>
<td>569,798</td>
<td data-sort="31652000">$31.65M</td>
<td>1.2%</td>
<td class="c-green" data-sort="17.1%">+17.1%</td>
<td>0.685%</td>
<td style="min-width:75px;text-align:center;">
<a rel="nofollow noopener" href="https://www.google.com/search?q=Emerald+Advisers+LLC+13F SEC" title="Search for Emerald Advisers LLC’s 10/29/2024 SEC report of Ultragenyx Pharmaceutical shares on Google" target="_blank"><img src="/images/insider-trades-icon-search.svg?v=2" width="27" height="27" alt="Search for SEC Filing on Google Icon" loading="lazy"></a>
</td>
</tr>
<tr class="even">
<td data-sort="20241029000000">10/29/2024</td>
<td>Van ECK Associates Corp</td>
<td>1,487</td>
<td data-sort="81000">$81K</td>
<td>0.0%</td>
<td class="c-red" data-sort="-23.5%">-23.5%</td>
<td>0.002%</td>
<td style="min-width:75px;text-align:center;">
<a rel="nofollow noopener" href="https://www.google.com/search?q=Van+ECK+Associates+Corp+13F SEC" title="Search for Van ECK Associates Corp’s 10/29/2024 SEC report of Ultragenyx Pharmaceutical shares on Google" target="_blank"><img src="/images/insider-trades-icon-search.svg?v=2" width="27" height="27" alt="Search for SEC Filing on Google Icon" loading="lazy"></a>
</td>
</tr>
<tr class="odd">
<td data-sort="20241029000000">10/29/2024</td>
<td>Emerald Mutual Fund Advisers Trust</td>
<td>429,302</td>
<td data-sort="23848000">$23.85M</td>
<td>1.2%</td>
<td class="c-green" data-sort="9.9%">+9.9%</td>
<td>0.516%</td>
<td style="min-width:75px;text-align:center;">
<a rel="nofollow noopener" href="https://www.google.com/search?q=Emerald+Mutual+Fund+Advisers+Trust+13F SEC" title="Search for Emerald Mutual Fund Advisers Trust’s 10/29/2024 SEC report of Ultragenyx Pharmaceutical shares on Google" target="_blank"><img src="/images/insider-trades-icon-search.svg?v=2" width="27" height="27" alt="Search for SEC Filing on Google Icon" loading="lazy"></a>
</td>
</tr>
<tr class="even">
<td data-sort="20241028000000">10/28/2024</td>
<td>Oak Ridge Investments LLC</td>
<td>18,622</td>
<td data-sort="1034000">$1.03M</td>
<td>0.1%</td>
<td class="c-red" data-sort="-3.8%">-3.8%</td>
<td>0.022%</td>
<td style="min-width:75px;text-align:center;">
<a rel="nofollow noopener" href="https://www.google.com/search?q=Oak+Ridge+Investments+LLC+13F SEC" title="Search for Oak Ridge Investments LLC’s 10/28/2024 SEC report of Ultragenyx Pharmaceutical shares on Google" target="_blank"><img src="/images/insider-trades-icon-search.svg?v=2" width="27" height="27" alt="Search for SEC Filing on Google Icon" loading="lazy"></a>
</td>
</tr>
<tr class="odd">
<td data-sort="20241028000000">10/28/2024</td>
<td>US Bancorp DE</td>
<td>4,149</td>
<td data-sort="230000">$0.23M</td>
<td>0.0%</td>
<td class="c-red" data-sort="-41.3%">-41.3%</td>
<td>0.005%</td>
<td style="min-width:75px;text-align:center;">
<a rel="nofollow noopener" href="https://www.google.com/search?q=US+Bancorp+DE+13F SEC" title="Search for US Bancorp DE’s 10/28/2024 SEC report of Ultragenyx Pharmaceutical shares on Google" target="_blank"><img src="/images/insider-trades-icon-search.svg?v=2" width="27" height="27" alt="Search for SEC Filing on Google Icon" loading="lazy"></a>
</td>
</tr>
<tr class="even">
<td data-sort="20241025000000">10/25/2024</td>
<td>Pinnacle Associates Ltd.</td>
<td>119,360</td>
<td data-sort="6630000">$6.63M</td>
<td>0.1%</td>
<td class="c-red" data-sort="-25.9%">-25.9%</td>
<td>0.144%</td>
<td style="min-width:75px;text-align:center;">
<a rel="nofollow noopener" href="https://www.google.com/search?q=Pinnacle+Associates+Ltd.+13F SEC" title="Search for Pinnacle Associates Ltd.’s 10/25/2024 SEC report of Ultragenyx Pharmaceutical shares on Google" target="_blank"><img src="/images/insider-trades-icon-search.svg?v=2" width="27" height="27" alt="Search for SEC Filing on Google Icon" loading="lazy"></a>
</td>
</tr>
<tr class="odd">
<td data-sort="20241025000000">10/25/2024</td>
<td>China Universal Asset Management Co. Ltd.</td>
<td>17,726</td>
<td data-sort="985000">$0.99M</td>
<td>0.1%</td>
<td class="c-green" data-sort="81.5%">+81.5%</td>
<td>0.021%</td>
<td style="min-width:75px;text-align:center;">
<a rel="nofollow noopener" href="https://www.google.com/search?q=China+Universal+Asset+Management+Co.+Ltd.+13F SEC" title="Search for China Universal Asset Management Co. Ltd.’s 10/25/2024 SEC report of Ultragenyx Pharmaceutical shares on Google" target="_blank"><img src="/images/insider-trades-icon-search.svg?v=2" width="27" height="27" alt="Search for SEC Filing on Google Icon" loading="lazy"></a>
</td>
</tr>
<tr class="even">
<td data-sort="20241025000000">10/25/2024</td>
<td>abrdn plc</td>
<td>253,304</td>
<td data-sort="14071000">$14.07M</td>
<td>0.0%</td>
<td class="c-red" data-sort="-11.0%">-11.0%</td>
<td>0.305%</td>
<td style="min-width:75px;text-align:center;">
<a rel="nofollow noopener" href="https://www.google.com/search?q=abrdn+plc+13F SEC" title="Search for abrdn plc’s 10/25/2024 SEC report of Ultragenyx Pharmaceutical shares on Google" target="_blank"><img src="/images/insider-trades-icon-search.svg?v=2" width="27" height="27" alt="Search for SEC Filing on Google Icon" loading="lazy"></a>
</td>
</tr>
<tr class="odd">
<td data-sort="20241025000000">10/25/2024</td>
<td>Pallas Capital Advisors LLC</td>
<td>10,904</td>
<td data-sort="598000">$0.60M</td>
<td>0.0%</td>
<td data-sort="0">N/A</td>
<td>0.013%</td>
<td style="min-width:75px;text-align:center;">
<a rel="nofollow noopener" href="https://www.google.com/search?q=Pallas+Capital+Advisors+LLC+13F SEC" title="Search for Pallas Capital Advisors LLC’s 10/25/2024 SEC report of Ultragenyx Pharmaceutical shares on Google" target="_blank"><img src="/images/insider-trades-icon-search.svg?v=2" width="27" height="27" alt="Search for SEC Filing on Google Icon" loading="lazy"></a>
</td>
</tr>
<tr class="even">
<td data-sort="20241024000000">10/24/2024</td>
<td>Wealth Enhancement Advisory Services LLC</td>
<td>21,753</td>
<td data-sort="1208000">$1.21M</td>
<td>0.0%</td>
<td class="c-green" data-sort="195.6%">+195.6%</td>
<td>0.024%</td>
<td style="min-width:75px;text-align:center;">
<a rel="nofollow noopener" href="https://www.google.com/search?q=Wealth+Enhancement+Advisory+Services+LLC+13F SEC" title="Search for Wealth Enhancement Advisory Services LLC’s 10/24/2024 SEC report of Ultragenyx Pharmaceutical shares on Google" target="_blank"><img src="/images/insider-trades-icon-search.svg?v=2" width="27" height="27" alt="Search for SEC Filing on Google Icon" loading="lazy"></a>
</td>
</tr>
<tr class="odd">
<td data-sort="20241023000000">10/23/2024</td>
<td>Mirae Asset Global Investments Co. Ltd.</td>
<td>3,333</td>
<td data-sort="181000">$0.18M</td>
<td>0.0%</td>
<td class="c-green" data-sort="34.3%">+34.3%</td>
<td>0.004%</td>
<td style="min-width:75px;text-align:center;">
<a rel="nofollow noopener" href="https://www.google.com/search?q=Mirae+Asset+Global+Investments+Co.+Ltd.+13F SEC" title="Search for Mirae Asset Global Investments Co. Ltd.’s 10/23/2024 SEC report of Ultragenyx Pharmaceutical shares on Google" target="_blank"><img src="/images/insider-trades-icon-search.svg?v=2" width="27" height="27" alt="Search for SEC Filing on Google Icon" loading="lazy"></a>
</td>
</tr>
<tr class="even">
<td data-sort="20241023000000">10/23/2024</td>
<td>Values First Advisors Inc.</td>
<td>1,010</td>
<td data-sort="56000">$56K</td>
<td>0.0%</td>
<td data-sort="0">N/A</td>
<td>0.001%</td>
<td style="min-width:75px;text-align:center;">
<a rel="nofollow noopener" href="https://www.google.com/search?q=Values+First+Advisors+Inc.+13F SEC" title="Search for Values First Advisors Inc.’s 10/23/2024 SEC report of Ultragenyx Pharmaceutical shares on Google" target="_blank"><img src="/images/insider-trades-icon-search.svg?v=2" width="27" height="27" alt="Search for SEC Filing on Google Icon" loading="lazy"></a>
</td>
</tr>
<tr class="odd">
<td data-sort="20241023000000">10/23/2024</td>
<td>Assenagon Asset Management S.A.</td>
<td>145,433</td>
<td data-sort="8079000">$8.08M</td>
<td>0.0%</td>
<td class="c-green" data-sort="2.3%">+2.3%</td>
<td>0.158%</td>
<td style="min-width:75px;text-align:center;">
<a rel="nofollow noopener" href="https://www.google.com/search?q=Assenagon+Asset+Management+S.A.+13F SEC" title="Search for Assenagon Asset Management S.A.’s 10/23/2024 SEC report of Ultragenyx Pharmaceutical shares on Google" target="_blank"><img src="/images/insider-trades-icon-search.svg?v=2" width="27" height="27" alt="Search for SEC Filing on Google Icon" loading="lazy"></a>
</td>
</tr>
<tr class="even">
<td data-sort="20241023000000">10/23/2024</td>
<td>Hennion & Walsh Asset Management Inc.</td>
<td>78,095</td>
<td data-sort="4338000">$4.34M</td>
<td>0.2%</td>
<td class="c-green" data-sort="6.6%">+6.6%</td>
<td>0.085%</td>
<td style="min-width:75px;text-align:center;">
<a rel="nofollow noopener" href="https://www.google.com/search?q=Hennion++Walsh+Asset+Management+Inc.+13F SEC" title="Search for Hennion & Walsh Asset Management Inc.’s 10/23/2024 SEC report of Ultragenyx Pharmaceutical shares on Google" target="_blank"><img src="/images/insider-trades-icon-search.svg?v=2" width="27" height="27" alt="Search for SEC Filing on Google Icon" loading="lazy"></a>
</td>
</tr>
<tr class="odd">
<td data-sort="20241022000000">10/22/2024</td>
<td>International Assets Investment Management LLC</td>
<td>10,388</td>
<td data-sort="577000">$0.58M</td>
<td>0.0%</td>
<td class="c-green" data-sort="29,580.0%">+29,580.0%</td>
<td>0.011%</td>
<td style="min-width:75px;text-align:center;">
<a rel="nofollow noopener" href="https://www.google.com/search?q=International+Assets+Investment+Management+LLC+13F SEC" title="Search for International Assets Investment Management LLC’s 10/22/2024 SEC report of Ultragenyx Pharmaceutical shares on Google" target="_blank"><img src="/images/insider-trades-icon-search.svg?v=2" width="27" height="27" alt="Search for SEC Filing on Google Icon" loading="lazy"></a>
</td>
</tr>
<tr class="even">
<td data-sort="20241019000000">10/19/2024</td>
<td>Allspring Global Investments Holdings LLC</td>
<td>2,287</td>
<td data-sort="127000">$0.13M</td>
<td>0.0%</td>
<td class="c-red" data-sort="-31.3%">-31.3%</td>
<td>0.002%</td>
<td style="min-width:75px;text-align:center;">
<a rel="nofollow noopener" href="https://www.google.com/search?q=Allspring+Global+Investments+Holdings+LLC+13F SEC" title="Search for Allspring Global Investments Holdings LLC’s 10/19/2024 SEC report of Ultragenyx Pharmaceutical shares on Google" target="_blank"><img src="/images/insider-trades-icon-search.svg?v=2" width="27" height="27" alt="Search for SEC Filing on Google Icon" loading="lazy"></a>
</td>
</tr>
<tr class="odd">
<td data-sort="20241016000000">10/16/2024</td>
<td>nVerses Capital LLC</td>
<td>2,700</td>
<td data-sort="150000">$0.15M</td>
<td>0.1%</td>
<td class="c-green" data-sort="237.5%">+237.5%</td>
<td>0.003%</td>
<td style="min-width:75px;text-align:center;">
<a rel="nofollow noopener" href="https://www.google.com/search?q=nVerses+Capital+LLC+13F SEC" title="Search for nVerses Capital LLC’s 10/16/2024 SEC report of Ultragenyx Pharmaceutical shares on Google" target="_blank"><img src="/images/insider-trades-icon-search.svg?v=2" width="27" height="27" alt="Search for SEC Filing on Google Icon" loading="lazy"></a>
</td>
</tr>
<tr class="even">
<td data-sort="20241008000000">10/8/2024</td>
<td>CWM LLC</td>
<td>21,332</td>
<td data-sort="1185000">$1.19M</td>
<td>0.0%</td>
<td class="c-green" data-sort="9,552.5%">+9,552.5%</td>
<td>0.026%</td>
<td style="min-width:75px;text-align:center;">
<a rel="nofollow noopener" href="https://www.google.com/search?q=CWM+LLC+13F SEC" title="Search for CWM LLC’s 10/8/2024 SEC report of Ultragenyx Pharmaceutical shares on Google" target="_blank"><img src="/images/insider-trades-icon-search.svg?v=2" width="27" height="27" alt="Search for SEC Filing on Google Icon" loading="lazy"></a>
</td>
</tr>
<tr class="odd">
<td data-sort="20241005000000">10/5/2024</td>
<td>Handelsbanken Fonder AB</td>
<td>24,523</td>
<td data-sort="1362000">$1.36M</td>
<td>0.0%</td>
<td class="c-green" data-sort="15.0%">+15.0%</td>
<td>0.029%</td>
<td style="min-width:75px;text-align:center;">
<a rel="nofollow noopener" href="https://www.google.com/search?q=Handelsbanken+Fonder+AB+13F SEC" title="Search for Handelsbanken Fonder AB’s 10/5/2024 SEC report of Ultragenyx Pharmaceutical shares on Google" target="_blank"><img src="/images/insider-trades-icon-search.svg?v=2" width="27" height="27" alt="Search for SEC Filing on Google Icon" loading="lazy"></a>
</td>
</tr>
<tr class="even">
<td data-sort="20241003000000">10/3/2024</td>
<td>SG Americas Securities LLC</td>
<td>12,313</td>
<td data-sort="684000">$0.68M</td>
<td>0.0%</td>
<td class="c-red" data-sort="-22.6%">-22.6%</td>
<td>0.013%</td>
<td style="min-width:75px;text-align:center;">
<a rel="nofollow noopener" href="https://www.google.com/search?q=SG+Americas+Securities+LLC+13F SEC" title="Search for SG Americas Securities LLC’s 10/3/2024 SEC report of Ultragenyx Pharmaceutical shares on Google" target="_blank"><img src="/images/insider-trades-icon-search.svg?v=2" width="27" height="27" alt="Search for SEC Filing on Google Icon" loading="lazy"></a>
</td>
</tr>
<tr class="odd">
<td data-sort="20240916000000">9/16/2024</td>
<td>Point72 DIFC Ltd</td>
<td>2,669</td>
<td data-sort="110000">$0.11M</td>
<td>0.0%</td>
<td class="c-red" data-sort="-73.4%">-73.4%</td>
<td>0.003%</td>
<td style="min-width:75px;text-align:center;">
<a rel="nofollow noopener" href="https://www.google.com/search?q=Point72+DIFC+Ltd+13F SEC" title="Search for Point72 DIFC Ltd’s 9/16/2024 SEC report of Ultragenyx Pharmaceutical shares on Google" target="_blank"><img src="/images/insider-trades-icon-search.svg?v=2" width="27" height="27" alt="Search for SEC Filing on Google Icon" loading="lazy"></a>
</td>
</tr>
<tr class="even">
<td data-sort="20240829000000">8/29/2024</td>
<td>Maven Securities LTD</td>
<td>20,000</td>
<td data-sort="822000">$0.82M</td>
<td>0.0%</td>
<td class="c-green" data-sort="100.0%">+100.0%</td>
<td>0.024%</td>
<td style="min-width:75px;text-align:center;">
<a rel="nofollow noopener" href="https://www.google.com/search?q=Maven+Securities+LTD+13F SEC" title="Search for Maven Securities LTD’s 8/29/2024 SEC report of Ultragenyx Pharmaceutical shares on Google" target="_blank"><img src="/images/insider-trades-icon-search.svg?v=2" width="27" height="27" alt="Search for SEC Filing on Google Icon" loading="lazy"></a>
</td>
</tr>
<tr class="odd">
<td data-sort="20240827000000">8/27/2024</td>
<td>Clearbridge Investments LLC</td>
<td>2,353,804</td>
<td data-sort="96741000">$96.74M</td>
<td>0.1%</td>
<td class="c-red" data-sort="-2.0%">-2.0%</td>
<td>2.831%</td>
<td style="min-width:75px;text-align:center;">
<a rel="nofollow noopener" href="https://www.google.com/search?q=Clearbridge+Investments+LLC+13F SEC" title="Search for Clearbridge Investments LLC’s 8/27/2024 SEC report of Ultragenyx Pharmaceutical shares on Google" target="_blank"><img src="/images/insider-trades-icon-search.svg?v=2" width="27" height="27" alt="Search for SEC Filing on Google Icon" loading="lazy"></a>
</td>
</tr>
<tr class="even">
<td data-sort="20240821000000">8/21/2024</td>
<td>Truist Financial Corp</td>
<td>9,791</td>
<td data-sort="402000">$0.40M</td>
<td>0.0%</td>
<td class="c-red" data-sort="-3.2%">-3.2%</td>
<td>0.012%</td>
<td style="min-width:75px;text-align:center;">
<a rel="nofollow noopener" href="https://www.google.com/search?q=Truist+Financial+Corp+13F SEC" title="Search for Truist Financial Corp’s 8/21/2024 SEC report of Ultragenyx Pharmaceutical shares on Google" target="_blank"><img src="/images/insider-trades-icon-search.svg?v=2" width="27" height="27" alt="Search for SEC Filing on Google Icon" loading="lazy"></a>
</td>
</tr>
<tr class="odd">
<td data-sort="20240816000000">8/16/2024</td>
<td>Clearline Capital LP</td>
<td>32,961</td>
<td data-sort="1355000">$1.36M</td>
<td>0.0%</td>
<td data-sort="0">N/A</td>
<td>0.036%</td>
<td style="min-width:75px;text-align:center;">
<a rel="nofollow noopener" href="https://www.google.com/search?q=Clearline+Capital+LP+13F SEC" title="Search for Clearline Capital LP’s 8/16/2024 SEC report of Ultragenyx Pharmaceutical shares on Google" target="_blank"><img src="/images/insider-trades-icon-search.svg?v=2" width="27" height="27" alt="Search for SEC Filing on Google Icon" loading="lazy"></a>
</td>
</tr>
<tr class="even">
<td data-sort="20240816000000">8/16/2024</td>
<td>Algert Global LLC</td>
<td>50,322</td>
<td data-sort="2068000">$2.07M</td>
<td>0.1%</td>
<td class="c-green" data-sort="104.8%">+104.8%</td>
<td>0.055%</td>
<td style="min-width:75px;text-align:center;">
<a rel="nofollow noopener" href="https://www.google.com/search?q=Algert+Global+LLC+13F SEC" title="Search for Algert Global LLC’s 8/16/2024 SEC report of Ultragenyx Pharmaceutical shares on Google" target="_blank"><img src="/images/insider-trades-icon-search.svg?v=2" width="27" height="27" alt="Search for SEC Filing on Google Icon" loading="lazy"></a>
</td>
</tr>
<tr class="odd">
<td data-sort="20240816000000">8/16/2024</td>
<td>Frazier Life Sciences Management L.P.</td>
<td>425,000</td>
<td data-sort="17468000">$17.47M</td>
<td>0.8%</td>
<td data-sort="0">N/A</td>
<td>0.461%</td>
<td style="min-width:75px;text-align:center;">
<a rel="nofollow noopener" href="https://www.google.com/search?q=Frazier+Life+Sciences+Management+L.P.+13F SEC" title="Search for Frazier Life Sciences Management L.P.’s 8/16/2024 SEC report of Ultragenyx Pharmaceutical shares on Google" target="_blank"><img src="/images/insider-trades-icon-search.svg?v=2" width="27" height="27" alt="Search for SEC Filing on Google Icon" loading="lazy"></a>
</td>
</tr>
<tr class="even">
<td data-sort="20240816000000">8/16/2024</td>
<td>Driehaus Capital Management LLC</td>
<td>528,180</td>
<td data-sort="21708000">$21.71M</td>
<td>0.2%</td>
<td class="c-green" data-sort="35.7%">+35.7%</td>
<td>0.573%</td>
<td style="min-width:75px;text-align:center;">
<a rel="nofollow noopener" href="https://www.google.com/search?q=Driehaus+Capital+Management+LLC+13F SEC" title="Search for Driehaus Capital Management LLC’s 8/16/2024 SEC report of Ultragenyx Pharmaceutical shares on Google" target="_blank"><img src="/images/insider-trades-icon-search.svg?v=2" width="27" height="27" alt="Search for SEC Filing on Google Icon" loading="lazy"></a>
</td>
</tr>
<tr class="odd">
<td data-sort="20240815000000">8/15/2024</td>
<td>Susquehanna Portfolio Strategies LLC</td>
<td>7,147</td>
<td data-sort="294000">$0.29M</td>
<td>0.0%</td>
<td class="c-red" data-sort="-70.4%">-70.4%</td>
<td>0.008%</td>
<td style="min-width:75px;text-align:center;">
<a rel="nofollow noopener" href="https://www.google.com/search?q=Susquehanna+Portfolio+Strategies+LLC+13F SEC" title="Search for Susquehanna Portfolio Strategies LLC’s 8/15/2024 SEC report of Ultragenyx Pharmaceutical shares on Google" target="_blank"><img src="/images/insider-trades-icon-search.svg?v=2" width="27" height="27" alt="Search for SEC Filing on Google Icon" loading="lazy"></a>
</td>
</tr>
</tbody>
</table><em>Data available starting January 2016</em><br><br>
</div>
<div class="see-more-fade d-none">
<div class="container see-more-fade-inner">
<div class="c-blue see-more-button button">See Full Table</div>
</div>
</div>
</div>
<div class="bg-gray mt-1">
<div class="container" id="about">
<div id="company-description" class="d-sm-flex my-2">
<div style="flex: 0 1 250px; -ms-flex: 0 1 250px;text-align:center;">
<div class="bg-white p-1"><img style="max-height: 100px;width:auto;" src="https://www.insidertrades.com/logos/ultragenyx-pharmaceutical-inc-logo.png?v=20240503131906" title="Ultragenyx Pharmaceutical logo"
alt="Ultragenyx Pharmaceutical logo" height="247" width="600" loading="lazy"></div>
</div>
<div style="padding:.25rem 1rem;flex:1;-ms-flex:1;">
<div class="read-more-section clickable" data-heightcutoff="140"> Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the
treatment of rare and ultra-rare genetic diseases in North America, Latin America, Japan, Europe, and internationally. Its biologic products include Crysvita (burosumab), an antibody targeting fibroblast growth factor 23 for the
treatment of X-linked hypophosphatemia, as well as tumor-induced osteomalacia; Mepsevii, an enzyme replacement therapy for the treatment of children and adults with Mucopolysaccharidosis VII; Dojolvi for treating long-chain fatty acid
oxidation disorders; and Evkeeza (evinacumab) for the treatment of homozygous familial hypercholesterolemia. The company's products candidatures include DTX401, an adeno-associated virus 8 (AAV8) gene therapy clinical candidate for the
treatment of patients with glycogen storage disease type Ia; DTX301, an AAV8 gene therapy for the treatment of patients with ornithine transcarbamylase; UX143, a human monoclonal antibody for the treatment of osteogenesis imperfecta;
GTX-102, an antisense oligonucleotide for the treatment of Angelman syndrome; UX111, an AAV9 gene therapy product candidate for the treatment of patients with Sanfilippo syndrome type A, or MPS IIIA, a rare lysosomal storage disease;
UX701, for the treatment of Wilson disease; and UX053 for the treatment of glycogen storage disease type III. Ultragenyx Pharmaceutical Inc. has collaboration and license agreement with Kyowa Kirin Co., Ltd.; Saint Louis University;
Baylor Research Institute; REGENXBIO Inc.; Bayer Healthcare LLC; GeneTx; Mereo; University of Pennsylvania; Arcturus Therapeutics Holdings Inc.; Solid Biosciences Inc.; Regeneron; Abeona; and Daiichi Sankyo Co., Ltd. The company was
incorporated in 2010 and is headquartered in Novato, California.</div>
<div class="a-dark-green read-more-button">Read More <span class="sr-only"> on Ultragenyx Pharmaceutical</span></div>
</div>
</div>
</div>
</div>
<div class="container">
<div class="super-border-bottom">
<div class="row d-md-flex pb-1">
<div class="w-33 p-1">
<h4>Today's Range</h4>
<strong>Now: $41.50</strong>
<div style="overflow:hidden">
<div class="range-mini-chart"><span class="sr-only">Low: </span>$41.10<div class="range"><span class="range-quadrants"></span><span class="range-marker" style="left:47.06%"></span></div><span class="sr-only">High: </span>$41.95</div>
</div>
</div>
<div class="w-33 p-1">
<h4>50 Day Range</h4>
<strong>MA: $46.95</strong>
<div style="overflow:hidden">
<div class="range-mini-chart"><span class="sr-only">Low: </span>$41.15<div class="range"><span class="range-quadrants"></span><span class="range-marker" style="left:48.66%"></span></div><span class="sr-only">High: </span>$53.07</div>
</div>
</div>
<div class="w-33 p-1">
<h4>52 Week Range</h4>
<strong>Now: $41.50</strong>
<div style="overflow:hidden">
<div class="range-mini-chart"><span class="sr-only">Low: </span>$37.02<div class="range"><span class="range-quadrants"></span><span class="range-marker" style="left:19.19%"></span></div><span class="sr-only">High: </span>$60.37</div>
</div>
</div>
</div>
</div>
<div class="super-border-bottom">
<div class="row d-sm-flex pb-1">
<div class="w-33 p-1">
<h4>Volume</h4> 1,482,758 shs
</div>
<div class="w-33 p-1">
<h4>Average Volume</h4> 1,509,129 shs
</div>
<div class="w-33 p-1">
<h4>Market Capitalization</h4> $3.83 billion
</div>
</div>
</div>
<div class="super-border-bottom">
<div class="row d-sm-flex pb-1">
<div class="w-33 p-1">
<h4>P/E Ratio</h4> N/A
</div>
<div class="w-33 p-1">
<h4>Dividend Yield</h4> N/A
</div>
<div class="w-33 p-1">
<h4>Beta</h4> 0.56
</div>
</div>
</div>
</div>
<div class="container" id="insider-trading-faq">
<dl class="body-copy my-2 row d-md-flex flex-wrap" itemscope="" itemtype="https://schema.org/FAQPage">
<div class="w-50 col" itemscope="" itemprop="mainEntity" itemtype="https://schema.org/Question">
<dt>
<h4 id="question1" class="question h3 mt-0 c-dark-blue m-0 border-left b-dark-blue pl-5" itemprop="name text">Who are the company insiders with the largest holdings of Ultragenyx Pharmaceutical?</h4>
</dt>
<dd>
<div itemprop="acceptedAnswer" itemscope="" itemtype="https://schema.org/Answer" class="answer pl-5 pt-3">
<div itemprop="text" id="answer1">Ultragenyx Pharmaceutical's top insider shareholders include:<ol>
<li>Emil D Kakkis (CEO)</li>
<li>Thomas Richard Kassberg (EVP)</li>
<li>Howard Horn (CFO)</li>
<li>John Richard Pinion (Insider)</li>
<li>Dennis Karl Huang (Insider)</li>
<li>Karah Herdman Parschauer (EVP)</li>
<li>Erik Harris (EVP)</li>
<li>Eric Crombez (EVP)</li>
<li>Camille L Bedrosian (EVP)</li>
<li>Theodore Alan Huizenga (CAO)</li>
<li>Matthew K Fust (Director)</li>
<li>Corazon (Corsee) D Sanders (Director)</li>
</ol><a class="sr-only sr-only-focusable" href="https://www.insidertrades.com/ultragenyx-pharmaceutical-inc-stock/">Learn More about top insider investors at Ultragenyx Pharmaceutical.</a></div>
</div>
</dd>
</div>
</dl>
</div>
<script>
var chartPrefix = 'NASDAQ';
var chartSymbol = 'RARE';
var priceSeriesCurrencySymbol = "$";
var InsiderTradesSeries =
"ActualDate,Date,AmountBought,AmountSold,Currency\n01/01/2022,02/15/2022,0,1602749,$\n04/01/2022,05/15/2022,0,27321,$\n07/01/2022,08/15/2022,0,0,$\n10/01/2022,11/15/2022,0,287862,$\n01/01/2023,02/15/2023,0,221106,$\n04/01/2023,05/15/2023,0,416366,$\n07/01/2023,08/15/2023,0,352046,$\n10/01/2023,11/15/2023,0,2911233,$\n01/01/2024,02/15/2024,0,1639721,$\n04/01/2024,05/15/2024,0,518923,$\n07/01/2024,08/15/2024,0,2149446,$\n10/01/2024,11/15/2024,0,1302735,$\n01/01/2025,02/15/2025,0,0,$";
var SECFilingSeries =
"ActualDate,Date,AmountBought,AmountSold,Currency\n01/01/2022,02/15/2022,111438871,146756533,$\n04/01/2022,05/15/2022,36992768,14172623.5,$\n07/01/2022,08/15/2022,33092390.5,84395105.5,$\n10/01/2022,11/15/2022,179093416,273533513.5,$\n01/01/2023,02/15/2023,86271445,39949933.5,$\n04/01/2023,05/15/2023,87858944.5,51223491.5,$\n07/01/2023,08/15/2023,51610064,44004151.5,$\n10/01/2023,11/15/2023,85141317,50601323.5,$\n01/01/2024,02/15/2024,267557762.5,115255543,$\n04/01/2024,05/15/2024,71124028,9415312.5,$\n07/01/2024,08/15/2024,130413708.5,26958732,$\n10/01/2024,11/15/2024,123680790,213739649.5,$";
var priceSeries =
"Date,SharePrice\n01/01/2025,42.07\n01/02/2025,41.15\n01/03/2024,47.95\n01/03/2025,41.5\n01/04/2024,47.09\n01/05/2024,47.6\n01/06/2024,47.6\n01/07/2024,47.6\n01/08/2024,49.78\n01/09/2024,48.35\n01/10/2024,47.16\n01/11/2024,46.15\n01/12/2024,45.7\n01/13/2024,45.7\n01/14/2024,45.7\n01/15/2024,45.7\n01/16/2024,44\n01/17/2024,43.44\n01/18/2024,43.16\n01/19/2024,44.6\n01/20/2024,44.6\n01/21/2024,44.6\n01/22/2024,44.63\n01/23/2024,44.48\n01/24/2024,43.61\n01/25/2024,45.25\n01/26/2024,44.97\n01/27/2024,44.97\n01/28/2024,44.97\n01/29/2024,45.99\n01/30/2024,44.88\n01/31/2024,44.11\n02/01/2024,44.1\n02/02/2024,43.02\n02/03/2024,43.02\n02/04/2024,43.02\n02/05/2024,44.76\n02/06/2024,45.89\n02/07/2024,44.71\n02/08/2024,45.45\n02/09/2024,46.73\n02/10/2024,46.73\n02/11/2024,46.73\n02/12/2024,46.74\n02/13/2024,43.98\n02/14/2024,45.66\n02/15/2024,46.26\n02/16/2024,48.92\n02/17/2024,48.92\n02/18/2024,48.92\n02/19/2024,48.92\n02/20/2024,47.87\n02/21/2024,48.18\n02/22/2024,48.88\n02/23/2024,49.48\n02/24/2024,49.48\n02/25/2024,49.48\n02/26/2024,50.25\n02/27/2024,53.66\n02/28/2024,52.75\n02/29/2024,51.72\n03/01/2024,53.69\n03/02/2024,53.69\n03/03/2024,53.69\n03/04/2024,53.31\n03/05/2024,51.47\n03/06/2024,51.26\n03/07/2024,50.85\n03/08/2024,50.53\n03/09/2024,50.53\n03/10/2024,50.53\n03/11/2024,48.51\n03/12/2024,47.66\n03/13/2024,48.55\n03/14/2024,46.65\n03/15/2024,47.37\n03/16/2024,47.37\n03/17/2024,47.37\n03/18/2024,46.59\n03/19/2024,47\n03/20/2024,47.01\n03/21/2024,46.65\n03/22/2024,45.85\n03/23/2024,45.85\n03/24/2024,45.85\n03/25/2024,45.42\n03/26/2024,45.46\n03/27/2024,46.82\n03/28/2024,46.69\n03/29/2024,46.69\n03/30/2024,46.69\n03/31/2024,46.69\n04/01/2024,46.97\n04/02/2024,46.59\n04/03/2024,47.08\n04/04/2024,47.08\n04/05/2024,50.24\n04/06/2024,50.24\n04/07/2024,50.24\n04/08/2024,50.23\n04/09/2024,50.56\n04/10/2024,51.61\n04/11/2024,50.7\n04/12/2024,47\n04/13/2024,47\n04/14/2024,47\n04/15/2024,42.87\n04/16/2024,42.31\n04/17/2024,44.11\n04/18/2024,43.38\n04/19/2024,42.37\n04/20/2024,42.37\n04/21/2024,42.37\n04/22/2024,43.69\n04/23/2024,45.11\n04/24/2024,44.28\n04/25/2024,43.85\n04/26/2024,44.24\n04/27/2024,44.24\n04/28/2024,44.24\n04/29/2024,44.02\n04/30/2024,42.54\n05/01/2024,43.3\n05/02/2024,43.2\n05/03/2024,42.75\n05/04/2024,42.75\n05/05/2024,42.75\n05/06/2024,43.01\n05/07/2024,41.96\n05/08/2024,41.56\n05/09/2024,41.22\n05/10/2024,40.9\n05/11/2024,40.9\n05/12/2024,40.9\n05/13/2024,40.96\n05/14/2024,40.97\n05/15/2024,41.12\n05/16/2024,42.61\n05/17/2024,41.87\n05/18/2024,41.87\n05/19/2024,41.87\n05/20/2024,41.53\n05/21/2024,40.58\n05/22/2024,41.08\n05/23/2024,39.9\n05/24/2024,40.34\n05/25/2024,40.34\n05/26/2024,40.34\n05/27/2024,40.34\n05/28/2024,39.34\n05/29/2024,38.14\n05/30/2024,38.65\n05/31/2024,40.14\n06/01/2024,40.14\n06/02/2024,40.14\n06/03/2024,41.13\n06/04/2024,40.92\n06/05/2024,41.45\n06/06/2024,41.77\n06/07/2024,41.4\n06/08/2024,41.4\n06/09/2024,41.4\n06/10/2024,41.97\n06/11/2024,41.4\n06/12/2024,44.64\n06/13/2024,43.12\n06/14/2024,39.05\n06/15/2024,39.05\n06/16/2024,39.05\n06/17/2024,39.8\n06/18/2024,37.42\n06/19/2024,37.42\n06/20/2024,38.02\n06/21/2024,39.6\n06/22/2024,39.6\n06/23/2024,39.6\n06/24/2024,39.42\n06/25/2024,39.85\n06/26/2024,40.53\n06/27/2024,41.42\n06/28/2024,41.1\n06/29/2024,41.1\n06/30/2024,41.1\n07/01/2024,41.12\n07/02/2024,40.96\n07/03/2024,40.21\n07/04/2024,40.21\n07/05/2024,40.88\n07/06/2024,40.88\n07/07/2024,40.88\n07/08/2024,41.49\n07/09/2024,42.25\n07/10/2024,42.46\n07/11/2024,43.89\n07/12/2024,45.14\n07/13/2024,45.14\n07/14/2024,45.14\n07/15/2024,44.46\n07/16/2024,45.27\n07/17/2024,43.89\n07/18/2024,42.78\n07/19/2024,42.55\n07/20/2024,42.55\n07/21/2024,42.55\n07/22/2024,44.46\n07/23/2024,45.18\n07/24/2024,45.11\n07/25/2024,45.06\n07/26/2024,44.86\n07/27/2024,44.86\n07/28/2024,44.86\n07/29/2024,45.24\n07/30/2024,44.71\n07/31/2024,45.02\n08/01/2024,44.15\n08/02/2024,50.47\n08/03/2024,50.47\n08/04/2024,50.47\n08/05/2024,49.08\n08/06/2024,49.77\n08/07/2024,48.94\n08/08/2024,50.29\n08/09/2024,50.03\n08/10/2024,50.03\n08/11/2024,50.03\n08/12/2024,50.9\n08/13/2024,51.8\n08/14/2024,51.76\n08/15/2024,51.73\n08/16/2024,53.05\n08/17/2024,53.05\n08/18/2024,53.05\n08/19/2024,53.78\n08/20/2024,53.01\n08/21/2024,57.05\n08/22/2024,56.36\n08/23/2024,56.75\n08/24/2024,56.75\n08/25/2024,56.75\n08/26/2024,57.05\n08/27/2024,57.62\n08/28/2024,57.79\n08/29/2024,56.96\n08/30/2024,56.78\n08/31/2024,56.78\n09/01/2024,56.78\n09/02/2024,56.78\n09/03/2024,55.71\n09/04/2024,56.12\n09/05/2024,56.45\n09/06/2024,55.24\n09/07/2024,55.24\n09/08/2024,55.24\n09/09/2024,55.8\n09/10/2024,55.72\n09/11/2024,56.33\n09/12/2024,57.83\n09/13/2024,58.74\n09/14/2024,58.74\n09/15/2024,58.74\n09/16/2024,59.36\n09/17/2024,58.49\n09/18/2024,57.7\n09/19/2024,58.78\n09/20/2024,58.75\n09/21/2024,58.75\n09/22/2024,58.75\n09/23/2024,57.56\n09/24/2024,57.48\n09/25/2024,56.76\n09/26/2024,55.22\n09/27/2024,54.43\n09/28/2024,54.43\n09/29/2024,54.43\n09/30/2024,55.55\n10/01/2024,56.51\n10/02/2024,55.55\n10/03/2024,53.66\n10/04/2024,53.79\n10/05/2024,53.79\n10/06/2024,53.79\n10/07/2024,52.43\n10/08/2024,53.3\n10/09/2024,53.38\n10/10/2024,53.87\n10/11/2024,55.1\n10/12/2024,55.1\n10/13/2024,55.1\n10/14/2024,56.19\n10/15/2024,57.12\n10/16/2024,57.7\n10/17/2024,56.77\n10/18/2024,56.26\n10/19/2024,56.26\n10/20/2024,56.26\n10/21/2024,54.46\n10/22/2024,54.79\n10/23/2024,54.69\n10/24/2024,54.82\n10/25/2024,53.82\n10/26/2024,53.82\n10/27/2024,53.82\n10/28/2024,53.07\n10/29/2024,52.8\n10/30/2024,51.84\n10/31/2024,50.99\n11/01/2024,50.99\n11/02/2024,50.99\n11/03/2024,50.99\n11/04/2024,51.06\n11/05/2024,52.18\n11/06/2024,50.52\n11/07/2024,50.43\n11/08/2024,50.36\n11/09/2024,50.36\n11/10/2024,50.36\n11/11/2024,50.73\n11/12/2024,47.84\n11/13/2024,48.71\n11/14/2024,47.64\n11/15/2024,44.75\n11/16/2024,44.75\n11/17/2024,44.75\n11/18/2024,43.78\n11/19/2024,45.13\n11/20/2024,46.4\n11/21/2024,46.02\n11/22/2024,47.24\n11/23/2024,47.24\n11/24/2024,47.24\n11/25/2024,47.12\n11/26/2024,47.36\n11/27/2024,48.13\n11/28/2024,48.13\n11/29/2024,47.63\n11/30/2024,47.63\n12/01/2024,47.63\n12/02/2024,47.6\n12/03/2024,46.67\n12/04/2024,47.11\n12/05/2024,47.34\n12/06/2024,49.38\n12/07/2024,49.38\n12/08/2024,49.38\n12/09/2024,49.32\n12/10/2024,49.09\n12/11/2024,48.86\n12/12/2024,46.89\n12/13/2024,45.78\n12/14/2024,45.78\n12/15/2024,45.78\n12/16/2024,45.4\n12/17/2024,44.95\n12/18/2024,42.94\n12/19/2024,43.47\n12/20/2024,44.22\n12/21/2024,44.22\n12/22/2024,44.22\n12/23/2024,43.87\n12/24/2024,43.75\n12/25/2024,43.75\n12/26/2024,43.82\n12/27/2024,43.42\n12/28/2024,43.42\n12/29/2024,43.42\n12/30/2024,42.27\n12/31/2024,42.07";
</script>
</div>
</form>
Text Content
Skip to main content * Insiders * Latest Transactions * All Transactions * Insider Buying * Insider Selling * Companies * Consumer Discretionary * Finance * Computer and Technology * Oils/Energy * Retail/Wholesale * Medical * Business Services * Aerospace * Auto/Tires/Trucks * Financial Services * Education * About Insider Trading * Articles * News Alerts * Tools * All Tools * CEO Buys * CFO Buys * COO Buys * Double Buys * Triple Buys * Most Bought Stocks * Most Sold Stocks * Account * Log In * Contact Genesis leading the smart algo revolution? From Diversified Trading Institute | Ad I’m revealing an exciting breakthrough that can help trade the markets unlike anything you’ve ever seen before… Because with my BRAND NEW smart algo you’ll always have a constant stream of alerts firing off in your back pocket to choose from. Here’s why: It does all the heavy lifting for you… automatically. Stock Ticker, Entry Price, Profit Target, Stop Loss, and even an Individual Chart! You’ll want to see what I’ve put on this page right here RARE INSIDER TRADING * Insider Trading Chart * Insider Trading History * Frequently Asked Questions * About Insider Ownership Percentage: 5.80% Insider Buying (Last 12 Months): $0.00 Insider Selling (Last 12 Months): $5,610,824.29 ULTRAGENYX PHARMACEUTICAL INSIDER TRADING HISTORY CHART This chart shows the insider buying and selling history at Ultragenyx Pharmaceutical by year and by quarter. Skip ChartChart Data in Insider Trading History Table ULTRAGENYX PHARMACEUTICAL SHARE PRICE & PRICE HISTORY Current Price: $41.50 Price Change: ▲ Price Increase of +0.35 (0.85%) As of 01/3/2025 06:39 PM ET This chart shows the closing price history over time for RARE up to the past year. Skip Chart and Table DataPrice Data in Insider Trading History Table Days: 30 | 90 | 365 Target More Reliable Returns in 2025 From Unstoppable Prosperity | Ad [LIVE] How the Pros are Trading Options in 2025 Charles Payne reveals beginner-friendly options strategies for the New Year Just click here to claim your seat at the LIVE Power of Options event ULTRAGENYX PHARMACEUTICAL INSIDER TRADING HISTORY Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails12/30/2024Emil D KakkisCEOSell11,727$42.23$495,231.212,183,985 12/10/2024Emil D KakkisCEOSell8,273$50.00$413,650.002,195,712 10/10/2024Howard HornCFOSell7,465$52.76$393,853.4092,301 9/3/2024Emil D KakkisCEOSell20,000$55.85$1,117,000.002,223,985 9/3/2024Theodore Alan HuizengaCAOSell91$56.19$5,113.2941,551 8/6/2024Emil D KakkisCEOSell20,000$50.17$1,003,400.002,243,985 7/2/2024Corsee D. SandersDirectorSell584$40.98$23,932.3212,009 6/12/2024Karah Herdman ParschauerEVPSell9,806$45.00$441,270.0057,981 6/10/2024Corsee D. SandersDirectorSell1,737$41.10$71,390.707,248 4/18/2024Eric CrombezEVPSell142$44.10$6,262.2048,785 3/11/2024Thomas Richard KassbergEVPSell11,509$49.93$574,644.37252,823 3/7/2024Matthew K. FustDirectorSell12,195$50.88$620,481.6014,860 3/1/2024John Richard PinionInsiderSell4,173$53.76$224,340.4889,268 3/1/2024Karah Herdman ParschauerEVPSell3,756$53.76$201,922.5667,340 3/1/2024Theodore Alan HuizengaCAOSell341$53.76$18,332.1641,380 10/23/2023Thomas Richard KassbergEVPSell39,878$32.78$1,307,200.84246,860 10/19/2023Emil D KakkisCEOSell47,853$33.52$1,604,032.56599,743 9/7/2023Theodore Alan HuizengaCAOSell2,163$40.80$88,250.4023,614 9/5/2023Erik HarrisEVPSell6,000$37.96$227,760.0051,281 9/1/2023Theodore Alan HuizengaCAOSell970$37.15$36,035.5023,777 6/30/2023Corsee D. SandersDirectorSell585$46.76$27,354.608,985 6/19/2023Erik HarrisEVPSell305$48.20$14,701.0057,281 6/8/2023Corsee D. SandersDirectorSell1,485$51.65$76,700.259,570 5/18/2023John Richard PinionInsiderSell2,012$50.00$100,600.0074,744 5/4/2023Karah Herdman ParschauerEVPSell4,378$45.00$197,010.0051,982 3/1/2023Camille L. BedrosianEVPSell3,881$45.25$175,615.2546,720 3/1/2023Dennis Karl HuangInsiderSell389$45.65$17,757.8575,314 2/28/2023Theodore Alan HuizengaCAOSell639$43.40$27,732.6015,558 12/21/2022Theodore Alan HuizengaCAOSell2,031$43.96$89,282.7616,197 10/14/2022Mardi DierCFOSell1,629$40.16$65,420.6466,695 10/12/2022Mardi DierCFOSell3,484$38.22$133,158.4868,324 6/19/2022Erik HarrisEVPSell295$54.78$16,160.1036,160 4/16/2022Theodore Alan HuizengaCAOSell132$84.55$11,160.6016,914 3/11/2022Thomas Richard KassbergEVPSell10,281$67.01$688,929.81 3/7/2022Karah Herdman ParschauerEVPSell5,140$62.95$323,563.00 3/1/2022Erik HarrisEVPSell2,713$66.62$180,740.06 3/1/2022John Richard PinionInsiderSell4,498$66.62$299,656.76 1/30/2022Camille L. BedrosianEVPSell1,657$66.30$109,859.10 See Full Table Why buying gold might be a mistake From DTI | Ad Something strange just happened with gold. With the recent Fed rate cut… My charts are showing a breakout signal I haven't seen in years. But for now, I'm not rushing to buy gold. In fact, I'm telling everyone I know to hold off. Because I believe there’s a far better way to play this upcoming surge. It's a method that could turn a 1% gold price change into gains like 59%, 118%, or even 228%. And it doesn't involve buying a single ounce of physical gold or even buying any regular gold stock. I've been trading gold for nearly 20 years now and this is my #1 recommended approach for trading gold right now. Most traders miss them completely… But for those who know how to spot them, it takes their trades to a whole new level. If you're interested, check out the recording here while the link's still up. SEC FILINGS (INSTITUTIONAL OWNERSHIP CHANGES) FOR ULTRAGENYX PHARMACEUTICAL (NASDAQ:RARE) 97.67% of Ultragenyx Pharmaceutical stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock. INSTITUTIONAL BUYING AND SELLING BY QUARTER This chart shows the instiutional buying and selling at RARE by year and by quarter. Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table ULTRAGENYX PHARMACEUTICAL INSTITUTIONAL TRADING HISTORY Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails12/26/2024JPMorgan Chase & Co.213,210$11.84M0.0%-3.5%0.231%12/19/2024Principal Financial Group Inc.86,440$4.80M0.0%+740.0%0.094%11/27/2024Franklin Resources Inc.218,903$12.30M0.0%-25.5%0.237%11/25/2024Wilmington Savings Fund Society FSB1,489$83K0.0%N/A0.002%11/16/2024Geode Capital Management LLC1,571,081$87.30M0.0%+4.4%1.701%11/15/2024M&T Bank Corp6,992$0.39M0.0%+8.1%0.008%11/15/2024Frazier Life Sciences Management L.P.633,715$35.20M1.4%+49.1%0.686%11/15/2024Barclays PLC79,546$4.42M0.0%-66.4%0.086%11/15/2024Public Employees Retirement System of Ohio32,734$1.82M0.0%-1.6%0.035%11/15/2024Nomura Asset Management Co. Ltd.1,669$93K0.0%N/A0.002%11/15/2024Y Intercept Hong Kong Ltd19,151$1.06M0.1%+193.1%0.021%11/15/2024XTX Topco Ltd14,629$0.81M0.1%+95.2%0.016%11/15/2024Wellington Management Group LLP4,165,424$231.39M0.0%-8.6%4.511%11/15/2024Two Sigma Advisers LP987,800$54.87M0.1%+123.4%1.070%11/15/2024Sphera Funds Management LTD.195,349$10.85M1.7%-33.5%0.212%11/15/2024State Street Corp2,664,077$147.99M0.0%-1.2%2.885%11/15/2024Stifel Financial Corp20,961$1.16M0.0%-4.0%0.023%11/15/2024RTW Investments LP1,968,002$109.32M1.6%-39.6%2.131%11/15/2024Point72 DIFC Ltd14,517$0.81M0.0%+443.9%0.016%11/15/2024Point72 Asset Management L.P.653,660$36.31M0.1%+35.9%0.708%11/15/2024Parkman Healthcare Partners LLC109,468$6.08M0.8%+9.5%0.119%11/15/2024Motley Fool Asset Management LLC141,649$8.01M0.5%+0.3%0.153%11/15/2024Motley Fool Wealth Management LLC168,015$9.33M0.5%-1.4%0.182%11/15/2024NFJ Investment Group LLC38,131$2.12M0.1%-4.4%0.041%11/15/2024Ikarian Capital LLC179,000$9.94M1.3%N/A0.194%11/15/2024Jacobs Levy Equity Management Inc.97,960$5.44M0.0%-84.6%0.106%11/15/2024Janus Henderson Group PLC36,543$2.03M0.0%-49.1%0.040%11/15/2024Cinctive Capital Management LP15,902$0.88M0.0%-87.4%0.017%11/15/2024Benjamin Edwards Inc.6,084$0.34M0.0%N/A0.007%11/15/2024Baker BROS. Advisors LP1,576,114$87.55M0.9%+7.5%1.707%11/15/2024Bamco Inc. NY48,000$2.67M0.0%N/A0.052%11/15/2024Point72 Hong Kong Ltd10,020$0.56M0.0%N/A0.011%11/15/2024Erste Asset Management GmbH15,010$0.82M0.0%N/A0.016%11/15/2024True Wealth Design LLC778$43K0.0%N/A0.001%11/14/2024PDT Partners LLC66,193$3.68M0.3%+26.1%0.072%11/14/2024Fred Alger Management LLC536,298$29.79M0.1%-2.3%0.581%11/14/2024Verition Fund Management LLC77,306$4.29M0.0%-43.7%0.084%11/14/2024Captrust Financial Advisors11,428$0.64M0.0%+129.3%0.012%11/14/2024Vestal Point Capital LP750,000$41.66M3.2%-58.3%0.812%11/14/2024Capstone Investment Advisors LLC13,089$0.73M0.0%N/A0.014%11/14/2024Suvretta Capital Management LLC1,151,314$63.96M2.0%-44.1%1.247%11/14/2024Hantz Financial Services Inc.3,499$0.19M0.0%N/A0.004%11/14/2024Alkeon Capital Management LLC3,011,716$167.30M0.3%+34.3%3.261%11/14/2024UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC177,756$9.87M0.0%+0.5%0.192%11/14/2024Acuta Capital Partners LLC25,100$1.39M1.1%N/A0.027%11/13/2024BNP Paribas Financial Markets28,831$1.60M0.0%-57.3%0.031%11/13/2024FMR LLC637,821$35.43M0.0%-1.5%0.691%11/13/2024The Manufacturers Life Insurance Company238,055$13.22M0.0%-3.7%0.258%11/12/2024Pitcairn Co.10,584$0.59M0.0%-12.1%0.011%11/12/2024Algert Global LLC73,902$4.11M0.1%+46.9%0.080%11/12/2024Cerity Partners LLC31,919$1.77M0.0%N/A0.035%11/12/2024Charles Schwab Investment Management Inc.594,521$33.03M0.0%+10.6%0.644%11/12/2024Massachusetts Financial Services Co. MA542,373$30.13M0.0%+46.5%0.587%11/8/2024BNP PARIBAS ASSET MANAGEMENT Holding S.A.724,182$40.23M0.1%-12.8%0.786%11/8/2024Connor Clark & Lunn Investment Management Ltd.75,265$4.18M0.0%-53.8%0.082%11/8/2024B. Metzler seel. Sohn & Co. Holding AG23,817$1.32M0.0%N/A0.026%11/7/2024Quest Partners LLC2,145$0.12M0.0%N/A0.002%11/7/2024Swiss National Bank159,152$8.84M0.0%+9.1%0.173%11/6/2024Mutual of America Capital Management LLC5,780$0.32M0.0%N/A0.006%11/6/2024Natixis Advisors LLC52,562$2.92M0.0%+290.0%0.057%11/6/2024KBC Group NV2,568$0.14M0.0%+24.5%0.003%11/6/2024Pier 88 Investment Partners LLC22,540$1.25M0.3%-13.2%0.024%11/6/2024Angeles Investment Advisors LLC5,911$0.33M0.0%-11.0%0.006%11/5/2024Victory Capital Management Inc.10,948$0.61M0.0%+8.8%0.012%11/5/2024GSA Capital Partners LLP11,508$0.64M0.0%-26.1%0.012%11/5/2024WCM Investment Management LLC145,349$7.91M0.0%-6.0%0.158%11/4/2024State of New Jersey Common Pension Fund D34,769$1.93M0.0%-28.7%0.038%11/2/2024Privium Fund Management B.V.242,512$13.47M3.4%-3.6%0.263%11/1/2024Atria Investments Inc4,836$0.27M0.0%N/A0.005%11/1/2024Capital Performance Advisors LLP1,934$0.11M0.0%N/A0.002%10/31/2024Principal Financial Group Inc.86,440$4.80M0.0%+740.0%0.104%10/29/2024Emerald Advisers LLC569,798$31.65M1.2%+17.1%0.685%10/29/2024Van ECK Associates Corp1,487$81K0.0%-23.5%0.002%10/29/2024Emerald Mutual Fund Advisers Trust429,302$23.85M1.2%+9.9%0.516%10/28/2024Oak Ridge Investments LLC18,622$1.03M0.1%-3.8%0.022%10/28/2024US Bancorp DE4,149$0.23M0.0%-41.3%0.005%10/25/2024Pinnacle Associates Ltd.119,360$6.63M0.1%-25.9%0.144%10/25/2024China Universal Asset Management Co. Ltd.17,726$0.99M0.1%+81.5%0.021%10/25/2024abrdn plc253,304$14.07M0.0%-11.0%0.305%10/25/2024Pallas Capital Advisors LLC10,904$0.60M0.0%N/A0.013%10/24/2024Wealth Enhancement Advisory Services LLC21,753$1.21M0.0%+195.6%0.024%10/23/2024Mirae Asset Global Investments Co. Ltd.3,333$0.18M0.0%+34.3%0.004%10/23/2024Values First Advisors Inc.1,010$56K0.0%N/A0.001%10/23/2024Assenagon Asset Management S.A.145,433$8.08M0.0%+2.3%0.158%10/23/2024Hennion & Walsh Asset Management Inc.78,095$4.34M0.2%+6.6%0.085%10/22/2024International Assets Investment Management LLC10,388$0.58M0.0%+29,580.0%0.011%10/19/2024Allspring Global Investments Holdings LLC2,287$0.13M0.0%-31.3%0.002%10/16/2024nVerses Capital LLC2,700$0.15M0.1%+237.5%0.003%10/8/2024CWM LLC21,332$1.19M0.0%+9,552.5%0.026%10/5/2024Handelsbanken Fonder AB24,523$1.36M0.0%+15.0%0.029%10/3/2024SG Americas Securities LLC12,313$0.68M0.0%-22.6%0.013%9/16/2024Point72 DIFC Ltd2,669$0.11M0.0%-73.4%0.003%8/29/2024Maven Securities LTD20,000$0.82M0.0%+100.0%0.024%8/27/2024Clearbridge Investments LLC2,353,804$96.74M0.1%-2.0%2.831%8/21/2024Truist Financial Corp9,791$0.40M0.0%-3.2%0.012%8/16/2024Clearline Capital LP32,961$1.36M0.0%N/A0.036%8/16/2024Algert Global LLC50,322$2.07M0.1%+104.8%0.055%8/16/2024Frazier Life Sciences Management L.P.425,000$17.47M0.8%N/A0.461%8/16/2024Driehaus Capital Management LLC528,180$21.71M0.2%+35.7%0.573%8/15/2024Susquehanna Portfolio Strategies LLC7,147$0.29M0.0%-70.4%0.008% Data available starting January 2016 See Full Table Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in North America, Latin America, Japan, Europe, and internationally. Its biologic products include Crysvita (burosumab), an antibody targeting fibroblast growth factor 23 for the treatment of X-linked hypophosphatemia, as well as tumor-induced osteomalacia; Mepsevii, an enzyme replacement therapy for the treatment of children and adults with Mucopolysaccharidosis VII; Dojolvi for treating long-chain fatty acid oxidation disorders; and Evkeeza (evinacumab) for the treatment of homozygous familial hypercholesterolemia. The company's products candidatures include DTX401, an adeno-associated virus 8 (AAV8) gene therapy clinical candidate for the treatment of patients with glycogen storage disease type Ia; DTX301, an AAV8 gene therapy for the treatment of patients with ornithine transcarbamylase; UX143, a human monoclonal antibody for the treatment of osteogenesis imperfecta; GTX-102, an antisense oligonucleotide for the treatment of Angelman syndrome; UX111, an AAV9 gene therapy product candidate for the treatment of patients with Sanfilippo syndrome type A, or MPS IIIA, a rare lysosomal storage disease; UX701, for the treatment of Wilson disease; and UX053 for the treatment of glycogen storage disease type III. Ultragenyx Pharmaceutical Inc. has collaboration and license agreement with Kyowa Kirin Co., Ltd.; Saint Louis University; Baylor Research Institute; REGENXBIO Inc.; Bayer Healthcare LLC; GeneTx; Mereo; University of Pennsylvania; Arcturus Therapeutics Holdings Inc.; Solid Biosciences Inc.; Regeneron; Abeona; and Daiichi Sankyo Co., Ltd. The company was incorporated in 2010 and is headquartered in Novato, California. Read More on Ultragenyx Pharmaceutical TODAY'S RANGE Now: $41.50 Low: $41.10 High: $41.95 50 DAY RANGE MA: $46.95 Low: $41.15 High: $53.07 52 WEEK RANGE Now: $41.50 Low: $37.02 High: $60.37 VOLUME 1,482,758 shs AVERAGE VOLUME 1,509,129 shs MARKET CAPITALIZATION $3.83 billion P/E RATIO N/A DIVIDEND YIELD N/A BETA 0.56 WHO ARE THE COMPANY INSIDERS WITH THE LARGEST HOLDINGS OF ULTRAGENYX PHARMACEUTICAL? Ultragenyx Pharmaceutical's top insider shareholders include: 1. Emil D Kakkis (CEO) 2. Thomas Richard Kassberg (EVP) 3. Howard Horn (CFO) 4. John Richard Pinion (Insider) 5. Dennis Karl Huang (Insider) 6. Karah Herdman Parschauer (EVP) 7. Erik Harris (EVP) 8. Eric Crombez (EVP) 9. Camille L Bedrosian (EVP) 10. Theodore Alan Huizenga (CAO) 11. Matthew K Fust (Director) 12. Corazon (Corsee) D Sanders (Director) Learn More about top insider investors at Ultragenyx Pharmaceutical. Genesis leading the smart algo revolution? From Diversified Trading Institute | Ad I’m revealing an exciting breakthrough that can help trade the markets unlike anything you’ve ever seen before… Because with my BRAND NEW smart algo you’ll always have a constant stream of alerts firing off in your back pocket to choose from. Here’s why: It does all the heavy lifting for you… automatically. Stock Ticker, Entry Price, Profit Target, Stop Loss, and even an Individual Chart! You’ll want to see what I’ve put on this page right here About InsiderTrades.com | Contact © MarketBeat Media, LLC dba InsiderTrades.com™ 2019-2025. All rights reserved. 345 N Reid Place, Suite 620, Sioux Falls, SD 57103. InsiderTrades.com provides comprehensive coverage of insider trading, including recent insider buying, recent insider selling, and education about insider trading. InsiderTrades.com does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security. Our Accessibility Statement © 2025 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.